<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">47887</article-id><article-id pub-id-type="doi">10.7554/eLife.47887</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Neural stem cell temporal patterning and brain tumour growth rely on oxidative phosphorylation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-95503"><name><surname>van den Ameele</surname><given-names>Jelle</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2744-0810</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1051"><name><surname>Brand</surname><given-names>Andrea H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2089-6954</contrib-id><email>a.brand@gurdon.cam.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>The Gurdon Institute</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Physiology, Development and Neuroscience</institution><institution>University of Cambridge</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role>Reviewing Editor</role><aff><institution>New York University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Senior Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>09</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e47887</elocation-id><history><date date-type="received" iso-8601-date="2019-04-23"><day>23</day><month>04</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-09-11"><day>11</day><month>09</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, van den Ameele and Brand</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>van den Ameele and Brand</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-47887-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.47887.001</object-id><p>Translating advances in cancer research to clinical applications requires better insight into the metabolism of normal cells and tumour cells in vivo. Much effort has focused on understanding how glycolysis and oxidative phosphorylation (OxPhos) support proliferation, while their impact on other aspects of development and tumourigenesis remain largely unexplored. We found that inhibition of OxPhos in neural stem cells (NSCs) or tumours in the <italic>Drosophila</italic> brain not only decreases proliferation, but also affects many different aspects of stem cell behaviour. In NSCs, OxPhos dysfunction leads to a protracted G<sub>1</sub>/S-phase and results in delayed temporal patterning and reduced neuronal diversity. As a consequence, NSCs fail to undergo terminal differentiation, leading to prolonged neurogenesis into adulthood. Similarly, in brain tumours inhibition of OxPhos slows proliferation and prevents differentiation, resulting in reduced tumour heterogeneity. Thus, in vivo, highly proliferative stem cells and tumour cells require OxPhos for efficient growth and generation of diversity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neural stem cells</kwd><kwd>brain tumours</kwd><kwd>Warburg effect</kwd><kwd>oxidative phosphorylation</kwd><kwd>temporal patterning</kwd><kwd>tumour heterogeneity</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>103792</award-id><principal-award-recipient><name><surname>Brand</surname><given-names>Andrea H</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Brand</surname><given-names>Andrea H</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004410</institution-id><institution>European Molecular Biology Organization</institution></institution-wrap></funding-source><award-id>ALTF 1600_2014</award-id><principal-award-recipient><name><surname>van den Ameele</surname><given-names>Jelle</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>105839</award-id><principal-award-recipient><name><surname>van den Ameele</surname><given-names>Jelle</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>092096</award-id><principal-award-recipient><name><surname>Brand</surname><given-names>Andrea H</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C6946/A14492</award-id><principal-award-recipient><name><surname>Brand</surname><given-names>Andrea H</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Mitochondrial dysfunction in neural stem cells and brain tumour cells decreases proliferation and affects the generation of neuronal diversity and tumour heterogeneity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The observation that some cancer cells rely primarily on aerobic glycolysis for energy and biomass production (the Warburg effect) (<xref ref-type="bibr" rid="bib77">Vander Heiden et al., 2009</xref>; <xref ref-type="bibr" rid="bib82">Warburg, 1956</xref>) has often led to the assumption that the other main source of ATP, mitochondrial oxidative phosphorylation (OxPhos), is dispensable. However, it is becoming increasingly clear that many tumours do require mitochondrial activity for energy and biosynthesis and OxPhos is now frequently exploited as a therapeutic target in cancer (<xref ref-type="bibr" rid="bib24">Gui et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Molina et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Shi et al., 2019</xref>; <xref ref-type="bibr" rid="bib83">Weinberg and Chandel, 2015</xref>). OxPhos takes place at the inner mitochondrial membrane in five large protein complexes (Complex I-V), which together form the respiratory chain. Complexes I-IV transfer electrons from NADH to O<sub>2</sub> and use the released energy to translocate protons from the mitochondrial matrix into the intermembrane space. The resulting electrochemical gradient is then used by Complex V (ATP synthase) to generate ATP from ADP. Apart from the production of ATP, OxPhos is also directly involved in the generation of NAD<sup>+</sup>, orotate, fumarate and reactive oxygen species (ROS) and thus affects many cellular processes, such as nucleotide synthesis (<xref ref-type="bibr" rid="bib7">Birsoy et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Sullivan et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Sullivan et al., 2015</xref>), signalling pathway activity (<xref ref-type="bibr" rid="bib11">Chandel, 2014</xref>) and epigenetic modifications (<xref ref-type="bibr" rid="bib43">Lu and Thompson, 2012</xref>). The Warburg effect has since been interpreted as a normal adaptation to the metabolic requirements of proliferation, both in cancer cells and proliferating stem cells (<xref ref-type="bibr" rid="bib77">Vander Heiden et al., 2009</xref>). High glycolytic flux is thought to be required for a constant supply of biomass while OxPhos, apart from its role in production of ATP, primarily maintains the cellular redox balance (<xref ref-type="bibr" rid="bib7">Birsoy et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Sullivan et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Titov et al., 2016</xref>).</p><p>However, metabolic flux in cancer cells can be influenced by extrinsic and intrinsic factors such as substrate availability, oncogenic mutations and the tumour’s tissue and cell type of origin (<xref ref-type="bibr" rid="bib30">Hu et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Mayers et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Vander Heiden and DeBerardinis, 2017</xref>). Brain tumours in particular recapitulate many features of their tissue of origin and grow along a hierarchy reminiscent of normal brain development (<xref ref-type="bibr" rid="bib3">Azzarelli et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Genovese et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Lan et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Tiberi et al., 2014</xref>). An integrated understanding of the interactions between metabolism and cell identity in vivo, during both tumourigenesis and normal development, is therefore crucial to translate advances in cancer research to clinical applications.</p><p>Development of the <italic>Drosophila</italic> central nervous system (CNS) has been used extensively as a powerful reductionist model of human brain development and tumourigenesis in vivo (<xref ref-type="bibr" rid="bib9">Brand and Livesey, 2011</xref>; <xref ref-type="bibr" rid="bib26">Hakes and Brand, 2019</xref>; <xref ref-type="bibr" rid="bib79">Villegas, 2019</xref>). The CNS of <italic>Drosophila</italic> develops from rapidly cycling embryonic and larval neural stem cells (NSCs) that generate a wide variety of neurons and glia. Neuronal diversity is achieved primarily by spatial and temporal patterning, which confers specific identities on NSCs and their progeny according to their location and developmental time (<xref ref-type="bibr" rid="bib50">Miyares and Lee, 2019</xref>; <xref ref-type="bibr" rid="bib67">Technau et al., 2006</xref>). Neural stem cells (NSCs) in <italic>Drosophila</italic> and mammals are thought to generate ATP through aerobic glycolysis rather than OxPhos, whereas their neuronal progeny switch to mitochondrial respiration upon differentiation (<xref ref-type="bibr" rid="bib1">Agathocleous et al., 2012</xref>; <xref ref-type="bibr" rid="bib5">Beckervordersandforth et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Hall et al., 2012</xref>; <xref ref-type="bibr" rid="bib29">Homem et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Lange et al., 2016</xref>; <xref ref-type="bibr" rid="bib70">Tennessen et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Tennessen et al., 2011</xref>; <xref ref-type="bibr" rid="bib87">Zheng et al., 2016</xref>). Upregulation of aerobic glycolysis, reminiscent of the Warburg effect, has also been described in a number of <italic>Drosophila</italic> tumour paradigms (<xref ref-type="bibr" rid="bib18">Eichenlaub et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Wong et al., 2019</xref>). However, the interpretation that mitochondrial respiration is dispensable for normal <italic>Drosophila</italic> NSCs (<xref ref-type="bibr" rid="bib29">Homem et al., 2014</xref>) contrasts with the clear requirement for OxPhos to support cell cycle progression in the <italic>Drosophila</italic> eye disc (<xref ref-type="bibr" rid="bib45">Mandal et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Mandal et al., 2005</xref>; <xref ref-type="bibr" rid="bib55">Owusu-Ansah et al., 2008</xref>). Here, we investigate whether, and to what extent, <italic>Drosophila</italic> NSCs and brain tumours rely on oxidative phosphorylation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>OxPhos is required for brain tumour growth and heterogeneity</title><p>We first examined whether OxPhos is required in tumours generated by loss of the transcription factor, Prospero (Pros) (<xref ref-type="bibr" rid="bib10">Caussinus and Gonzalez, 2005</xref>; <xref ref-type="bibr" rid="bib13">Choksi et al., 2006</xref>), in which differentiating daughter-cells revert to a NSC-like fate (<xref ref-type="bibr" rid="bib13">Choksi et al., 2006</xref>) (<xref ref-type="fig" rid="fig1">Figure 1h</xref>). <italic>pros</italic> tumours are invasive upon transplantation and exhibit genomic instability over time (<xref ref-type="bibr" rid="bib10">Caussinus and Gonzalez, 2005</xref>). We used RNAi to knock down subunits of complex I (NDUFS1) or complex V (ATPsynα) in NSCs and tumour cells with a NSC-specific driver, Worniu-GAL4 (<xref ref-type="bibr" rid="bib2">Albertson et al., 2004</xref>). The complex I RNAi line has been validated previously (<xref ref-type="bibr" rid="bib21">Garcia et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Hermle et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Owusu-Ansah et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Pletcher et al., 2019</xref>); expression of the complex V RNAi in NSCs strongly reduced the levels of ATPsynα (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a–c</xref>). We also assessed mitochondrial morphology by stimulated emission-depletion (STED) super-resolution microscopy of mitochondria-targeted GFP (<xref ref-type="bibr" rid="bib59">Rizzuto et al., 1995</xref>). Both RNAi lines caused fragmentation of mitochondria (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2d–f</xref>), a known consequence of OxPhos dysfunction in mouse and human cells (<xref ref-type="bibr" rid="bib17">Duvezin-Caubet et al., 2006</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.47887.002</object-id><label>Figure 1.</label><caption><title>Brain tumours require OxPhos for growth.</title><p>(<bold>a–g</bold>) phospho Histone H3 (pH3) staining in the CNS of third instar larvae (<bold>L3</bold>) with NSC-specific expression (Wor-GAL4;Tub-GAL80<sup>ts</sup>) of control RNAi (<bold>a</bold>), Pros-RNAi (<bold>b,c</bold>), aPKC-CAAX (<bold>d,e</bold>) or Brat-RNAi (<bold>f, g</bold>), either without (<bold>b,d,f</bold>) or with (<bold>c,e,g</bold>) RNAi against a complex I subunit (NDUFS1). Maximum intensity projections through the entire CNS; dashed lines outline the CNS. (<bold>h</bold>) NSC lineages before and after tumourigenic transformation. (<bold>i,j</bold>) Brain size (<bold>i</bold>) and mitotic index of Dpn+ tumour cells (<bold>j</bold>) from L3 larvae expressing the indicated transgenes in NSCs. Datapoints indicate individual brains from one to four biological replicates. (<bold>k,l</bold>) Dpn (red, <bold>k’,l’</bold>) and Imp (green, <bold>k’’,l’’</bold>) immunostaining in Pros-RNAi tumours, without (<bold>k</bold>) or with (<bold>l</bold>) a complex I RNAi. Scale bars are 100 µm (<bold>a–g</bold>) or 10 µm (<bold>k,l</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Brain tumours require OxPhos and glycolysis for their growth.</title><p>(<bold>a,b</bold>) pH3 in the CNS of L3 larvae. Maximum intensity projections through the CNS; dashed lines outline the CNS. (<bold>c</bold>) Brain size (area of CNS, maximum intensity projections) from L3 larvae. Datapoints indicate individual brains from one biological replicate. (<bold>d–f</bold>) TUNEL, GFP (NSCs, Wor-GAL4 &gt;mCD8 GFP) and Dpn (NSCs) staining in the VNC of L3 larvae with NSC-specific expression of the indicated transgenes; arrowheads indicate TUNEL-positive cells. (<bold>g</bold>) Dpn and Imp in aPKC-CAAX tumours with NSC-specific expression of complex I RNAi. Scale bars are 100 µm (<bold>a,b</bold>), 10 µm (<bold>d–f</bold>) or 5 µm (<bold>g</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>OxPhos RNAi in NSCs affects mitochondrial function.</title><p>(<bold>a–c</bold>) ATPsynα (mitochondria, Complex V subunit) and GFP (mitochondria in NSCs and their progeny; Wor-GAL4 &gt;Mito GFP) staining in the VNC of L3 larvae with NSC-specific expression of the indicated RNAi. Complex V RNAi (<bold>c</bold>) targets the <italic>Drosophila</italic> ATPsynα. (<bold>d–f</bold>) Representative STED super-resolution images of NSCs expressing mitochondria targeted GFP (Mito-GFP) and the indicated RNAi; dashed lines outline NSCs, the other cells are neuronal progeny with perdurance of Mito-GFP. (<bold>g–h</bold>) Measurement of ATP specifically in NSCs expressing a genetically encoded ATP FRET sensor together with the indicated RNAi. Baseline YFP fluorescence (<bold>g,h</bold>); pseudocoloured FRET/CFP ratio images are shown at baseline (<bold>g’,h’</bold>) and 25 min after application of 200 mM 2-deoxyglucose (2-DG) to inhibit glycolysis (<bold>g’’,h’’</bold>); dashed lines outline the CNS. (<bold>i</bold>) Quantification of FRET/CFP ratio over time; datapoints indicate individual NSCs from four brains in one biological replicate; the trendline indicates an exponential model fitted to the values. Findings were confirmed in two additional biological replicates (data not shown). Scale bars are 5 µm (<bold>d–f</bold>), 10 µm (<bold>a–c</bold>) or 50 µm (g,h).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig1-figsupp2-v2.tif"/></fig></fig-group><p>To our surprise, inhibition of OxPhos through knockdown of mitochondrial complex I or V in <italic>pros</italic> tumours caused a decrease in tumour growth and an overall reduction in brain size (<xref ref-type="fig" rid="fig1">Figure 1a–c,i</xref>). This result was comparable to the effect observed upon inhibition of glycolysis with an RNAi against aldolase (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a–c</xref>). This suggests that neither glycolysis nor OxPhos are sufficient to support brain tumour growth in vivo.</p><p>Next, we tested the requirement for OxPhos in different types of brain tumours. Constitutive activation of aPKC (aPKC-CAAX) leads to symmetric division of NSCs in the <italic>Drosophila</italic> brain (<xref ref-type="bibr" rid="bib40">Lee et al., 2006</xref>) (<xref ref-type="fig" rid="fig1">Figure 1h</xref>), whereas loss of <italic>brat</italic> results in dedifferentiation of the progeny of type II NSCs (<xref ref-type="bibr" rid="bib8">Bowman et al., 2008</xref>) (<xref ref-type="fig" rid="fig1">Figure 1h</xref>). In both aPKC-CAAX and <italic>brat</italic> tumours we found that knockdown of the complex I subunit, NDUFS1, strongly inhibited tumour growth and decreased overall brain size (<xref ref-type="fig" rid="fig1">Figure 1d–g,i</xref>). This was accompanied by a significant decrease in the mitotic index of tumourigenic NSCs (<xref ref-type="fig" rid="fig1">Figure 1j</xref>), consistent with mitochondrial metabolism playing a key role in regulating the proliferation rate of brain tumour cells. There was no obvious increase in apoptosis upon OxPhos inhibition in <italic>pros</italic> tumours, as assessed by TUNEL-staining (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1d–f</xref>).</p><p>Growth of <italic>pros</italic> mutant tumours is sustained by a small proportion of highly proliferative stem cells that express Imp (IGF-II mRNA-binding protein) (<xref ref-type="bibr" rid="bib23">Genovese et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Narbonne-Reveau et al., 2016</xref>). These tumour stem cells self-renew and generate more differentiated Imp-negative tumour cells with limited self-renewal capacity. We assessed whether OxPhos inhibition promotes the differentiation of these Imp-positive stem cells towards Imp-negative tumour cells, which could result in inhibition of tumour growth (<xref ref-type="bibr" rid="bib23">Genovese et al., 2018</xref>). However, after knockdown of complex I by targeted RNAi, most tumourigenic NSCs in <italic>pros</italic> and aPKC-CAAX tumours remained Imp-positive and differentiation into Imp-negative cells was reduced (<xref ref-type="fig" rid="fig1s1">Figure 1k,l—figure supplement 1g</xref>). Our results suggest that OxPhos inhibition does not lead to more aggressive tumours, but rather slows it down by decreasing the proliferation rate of the tumour cells.</p></sec><sec id="s2-2"><title>NSC proliferation depends on OxPhos</title><p>We found that, as for tumour cells, inhibition of OxPhos in NSCs throughout development resulted in smaller brains (<xref ref-type="fig" rid="fig1">Figure 1i</xref>; <xref ref-type="fig" rid="fig2">Figure 2a–d</xref>). This could not be explained by an overall developmental delay, as larval and pupal body length was similar to controls (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). In contrast, inhibition of glycolysis by NSC-specific knockdown of phosphofructokinase (PFK), aldolase or phosphoglycerate kinase (PGK) had no effect on brain size and knockdown of pyruvate kinase (PyK) only caused a slight reduction (<xref ref-type="fig" rid="fig2s2">Figure 2d—figure supplement 2a-d</xref> and data not shown).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.47887.005</object-id><label>Figure 2.</label><caption><title>OxPhos inhibition decreases NSC proliferation.</title><p>(<bold>a–c</bold>) pH3 staining in the CNS of L3 larvae. Maximum intensity projections through the entire CNS; dashed lines outline the CNS. (<bold>d</bold>) Brain size from L3 larvae. (<bold>e,f</bold>) Mitotic index (<bold>e</bold>) and 15 min EdU incorporation (<bold>f</bold>) in NSCs expressing the indicated RNAi (Wor-GAL4;Tub-GAL80<sup>ts</sup>). (<bold>g</bold>) Stills from time-lapse imaging of NSCs (<xref ref-type="video" rid="fig2video1">Figure 2—video 1</xref>) in the early third instar larval VNC with NSC-specific expression of GFP or Complex I RNAi. Arrowheads indicate mitoses of selected NSCs. Datapoints indicate individual brains from four (<bold>e</bold>), one (<bold>f</bold>) and two to four (<bold>d</bold>) biological replicates. Scale bars are 5 µm (<bold>g</bold>) or 100 µm (<bold>a–c</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title>OxPhos inhibition does not affect body size.</title><p>Wandering larvae (<bold>a,b</bold>) or pupae (<bold>c,d</bold>) with NSC-specific expression of the indicated RNAi. Length is shown in millimetres (mm). Datapoints indicate individual organisms from one biological replicate. Scale bars are 5 mm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.007</object-id><label>Figure 2—figure supplement 2.</label><caption><title>OxPhos inhibition does not increase apoptosis.</title><p>(<bold>a–d</bold>) pH3 staining in the CNS of L3 larvae with NSC-specific expression of the indicated RNAi. Maximum intensity projections through the entire CNS; dashed lines outline the CNS. (<bold>e–j</bold>) TUNEL, GFP (NSCs, Wor-GAL4 &gt;mCD8 GFP) and Broad staining in the VNC of L3 larvae. Maximum intensity projections through the VNC (<bold>e–g</bold>); dashed lines outline the CNS; arrowheads indicate TUNEL-positive cells. (<bold>k</bold>) Total number of TUNEL-positive cells in the thoracic VNC. Datapoints indicate individual brains from one biological replicate. Scale bars are 100 µm (<bold>a–d</bold>), 50 µm (<bold>e–g</bold>) or 10 µm (<bold>h–j</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig2-figsupp2-v2.tif"/></fig><media id="fig2video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-47887-fig2-video1.mp4"><object-id pub-id-type="doi">10.7554/eLife.47887.008</object-id><label>Figure 2—video 1.</label><caption><title>Mitochondrial dysfunction increases cell cycle length.</title><p>Time-lapse imaging of NSCs in the early third instar larval VNC (48 hr ALH at 29°C) expressing either two copies of UAS-mCD8-GFP (Control, left), or one copy of UAS-mCD8-GFP and UAS-ND75-TRIP (Complex I RNAi, right) under the control of Wor-GAL4. Images were taken every 5 min over a period of 3 hr. Red arrows indicate mitoses of selected NSCs. Scale bars are 20 µm.</p></caption></media><media id="fig2video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-47887-fig2-video2.mp4"><object-id pub-id-type="doi">10.7554/eLife.47887.009</object-id><label>Figure 2—video 2.</label><caption><title>Mitochondrial dysfunction increases cell cycle length.</title><p>Time-lapse imaging of NSCs in the late third instar larval VNC (wandering, 72 hr ALH at 29°C) expressing either one copy of UAS-mCD8-GFP (Control, left), or one copy of UAS-mCD8-GFP and UAS-ND75-TRIP (Complex I RNAi, right) under the control of Wor-GAL4. Images were taken every 3 min and 50 s over a period of 3 hr. Red arrows indicate mitoses of selected NSCs. Scale bars are 20 µm.</p></caption></media></fig-group><p>Complex I or V knockdown did not cause an increase in apoptosis in the VNC of third instar larvae (L3) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2e–k</xref>). However, mitotic index (<xref ref-type="fig" rid="fig2">Figure 2e</xref>) and incorporation of the S-phase marker 5-ethynyl-2’-deoxyuridine (EdU) (<xref ref-type="fig" rid="fig2">Figure 2f</xref>) were significantly reduced, indicating that NSCs rely on OxPhos for proliferation. Live imaging of NSCs in the ventral nerve cord (VNC) after complex I knockdown confirmed a striking increase in cell cycle time: NSC division was rarely observed in a 3 hr time window, whereas control NSCs divided between one and three times (<xref ref-type="fig" rid="fig2">Figure 2g</xref>; <xref ref-type="video" rid="fig2video1">Figure 2—videos 1</xref> and <xref ref-type="video" rid="fig2video2">2</xref>).</p><p>To investigate whether RNAi-mediated OxPhos inhibition affects ATP production in NSCs, we measured ATP concentration in vivo using a genetically encoded ATP FRET sensor (<xref ref-type="bibr" rid="bib76">Tsuyama et al., 2013</xref>). ATP concentration in NSCs in the L3 VNC was similar between controls and complex V knockdown (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2g–i</xref>). Acute pharmacological inhibition of glycolysis through application of 2-deoxyglucose to ex vivo cultured brains caused a drop in ATP levels in both conditions. However, this drop was significantly more rapid and severe in NSCs with prior complex V inhibition (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2g–i</xref>). This suggests that mitochondrial dysfunction results in rewiring of NSC metabolism to rely more on glycolysis for ATP production.</p></sec><sec id="s2-3"><title>OxPhos is required for temporal patterning of NSCs and their progeny</title><p>In order to generate the diversity of neurons and glia within the CNS, NSCs undergo temporal patterning. This allows them to generate progeny with different identities according to their developmental time (<xref ref-type="bibr" rid="bib50">Miyares and Lee, 2019</xref>). <italic>Drosophila</italic> NSCs in the larval VNC progress from an early identity marked by cytoplasmic Imp and nuclear Chinmo, to a late identity marked by cytoplasmic Syncrip (Syp) and nuclear Broad (<xref ref-type="bibr" rid="bib42">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Maurange et al., 2008</xref>) (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). We found that inhibition of OxPhos caused a defect in temporal patterning of larval NSCs. After knockdown of complex I, one third of NSCs in the VNC (32.0 ± 4.0%, mean ± s.e.m., n = 11 VNCs) failed to downregulate Imp expression (<xref ref-type="fig" rid="fig3s1">Figure 3b-e—figure supplement 1a-c</xref>) and some (9.1 ± 1.4%, n = 14 VNCs) even failed to differentiate into Syp-positive NSCs at the end of larval life (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1d–g</xref>). This is reminiscent of the failure to downregulate Imp and reduced differentiation in NSC-derived tumours. Immunostaining for other temporal markers (<xref ref-type="bibr" rid="bib46">Maurange et al., 2008</xref>; <xref ref-type="bibr" rid="bib50">Miyares and Lee, 2019</xref>) revealed a delay in the downregulation of the early temporal factors Castor and Chinmo, a decreased peak of expression of the switching factor Sevenup, and delayed upregulation of the late temporal factor Broad (<xref ref-type="fig" rid="fig3s1">Figure 3e—figure supplement 1h</xref>). Similar results were observed after knockdown of other subunits of complex I (NDUFA10, NDUFV1) or V (ATPsynα, ATPsynγ) in the VNC (<xref ref-type="fig" rid="fig3s1">Figure 3d—figure supplement 1i–m</xref>), and after OxPhos inhibition in the central brain (CB) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1n–p</xref>). Importantly, this was accompanied by a significant reduction in the number of NSC progeny expressing Broad and lacking Chinmo, indicators of late neuronal identity (<xref ref-type="fig" rid="fig3s2">Figure 3f-h—figure supplement 2</xref>). We conclude that OxPhos is required for NSCs to progress from an early to a late temporal fate.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.47887.010</object-id><label>Figure 3.</label><caption><title>OxPhos is required for temporal patterning of NSC and their progeny.</title><p>(<bold>a</bold>) Scheme of the major temporal transitions in larval NSCs. (<bold>b–d</bold>) Dpn and Imp expression in the VNC of L3 larvae. Arrowheads indicate Imp-positive NSCs. (<bold>e</bold>) Percentage of Dpn-positive NSCs in the thoracic VNC that express the indicated temporal marker at different time points after larval hatching (ALH) at 25°C. (<bold>f,g</bold>) Dpn (NSCs), Chinmo and Broad in the VNC of L3 larvae. (<bold>h</bold>) Absolute number of cells per NSC lineage in the VNC that express Chinmo or Broad; graph indicates mean + /- s.e.m. of 6 clones. Datapoints indicate individual brains from four (<bold>d</bold>), two (<bold>e</bold>) and one (<bold>h</bold>) biological replicates. Scale bars are 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.011</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Mitochondrial dysfunction in NSCs delays temporal patterning.</title><p>(<bold>a–c</bold>) Overview of Imp and Syp in the thoracic VNC of L3 larvae. Single confocal sections at comparable depths through the ventral side of the VNC; dashed lines outline the VNC; arrowheads indicate Imp-positive, Syp-negative NSCs. (<bold>d–g</bold>) Mira and Syp expression in the VNC of L3 larvae. Arrowheads indicate Syp-negative NSCs. (<bold>h</bold>) Percentage of Dpn- or Mira-positive NSCs in the thoracic VNC that express the indicated temporal marker at different time points after larval hatching (ALH) at 25°C. (<bold>i–m</bold>) Dpn and Imp in the VNC of L3 larvae. Arrowheads indicate Imp-positive NSCs. (<bold>n–p</bold>) Dpn and Imp in the CB of L3 larvae; (<bold>n’–p’</bold>) higher magnifications of the same genotypes as in (<bold>n–p</bold>). Single confocal sections at comparable depths through the ventral side of the CB; dashed lines outline the CB; arrowheads indicate Imp-positive NSCs. Datapoints indicate individual brains from two (<bold>g</bold>) or one (<bold>h</bold>) biological replicates. Scale bars are 50 µm (<bold>a–c,n–p</bold>) or 10 µm (<bold>d–f,i–m,n’–p’</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.012</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Delayed temporal patterning of NSCs affects their progeny.</title><p>(<bold>a–c</bold>) Overview of Chinmo and Broad in the thoracic VNC of L3 larvae. Single confocal sections at comparable depths through the ventral side of the VNC; dashed lines outline the VNC. (<bold>d–f</bold>) RFP (clones, negatively marked), Chinmo and Broad in the VNC of L3 larvae. Representative single confocal sections through a clone; dashed lines indicate the outline of a clone. Scale bars are 50 µm (<bold>a–c</bold>) or 10 µm (<bold>d–f</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig3-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Temporal patterning of NSCs is regulated at the G<sub>1</sub>/S transition</title><p>To test directly whether increasing cell cycle length inhibits NSC temporal progression, we slowed the cell cycle by expression of Myt1, Wee1 (<xref ref-type="bibr" rid="bib58">Price et al., 2002</xref>) or both, which delay the G<sub>2</sub>/M transition (<xref ref-type="fig" rid="fig4">Figure 4g</xref>) and strongly decrease final brain size (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a</xref>). However, this did not affect NSC temporal progression and no Imp-positive NSCs could be detected at the end of neurogenesis (<xref ref-type="fig" rid="fig4">Figure 4d–f,h</xref>). Next, we tested whether inhibition of the G<sub>1</sub>/S transition affects temporal progression by expression of Dacapo (Dap; the p21/p27/p57 homologue), or an activated form of Rb (Rbf280). Strikingly, many NSCs in the VNC expressed Imp continuously (Dap: 7.8 ± 1.2%, n = 15 VNCs; Rb: 24.2 ± 3.4%, n = 10 VNCs) (<xref ref-type="fig" rid="fig4">Figure 4a–c,h</xref>). When Dap and Rbf280 were co-expressed, a majority of NSCs remained positive for the early NSC marker Chinmo (80.4 ± 1.1%, n = 4 VNCs) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1b,c</xref>). The block in temporal patterning correlated with the decrease in mitotic index (<xref ref-type="fig" rid="fig4s1">Figure 4h—figure supplement 1d,e</xref>). Our data suggest that temporal patterning and generation of neuronal diversity are linked to cell cycle progression and that regulation occurs at the G<sub>1</sub>/S rather than the G<sub>2</sub>/M transition.</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.47887.013</object-id><label>Figure 4.</label><caption><title>G<sub>1</sub>/S progression drives temporal patterning.</title><p>(<bold>a–f</bold>) Dpn (NSCs), pH3 (mitosis) and Imp in the VNC of L3 larvae after NSC-specific expression of the indicated transgene. Arrowheads indicate Imp-positive NSCs. (<bold>g</bold>) Scheme depicting activity of the regulators of the G<sub>1</sub>/S and G<sub>2</sub>/M transitions that are used for misexpression in this study, and the Fly-FUCCI transgenes. (<bold>h</bold>) Percentage of Dpn-positive NSCs that express Imp in L3 larvae. (<bold>i–k</bold>) L3 larvae with NSC-specific expression of the Fly-FUCCI system, together with control RNAi or complex I RNAi. Outlines indicate Dpn-positive nuclei (<bold>i,j</bold>). The percentage of Dpn-positive NSCs in the VNC that are positive for either GFP (<bold>G<sub>1</sub></bold>), RFP (<bold>S</bold>), a combination of GFP and RFP (G<sub>2</sub>/M) or none (G<sub>1</sub>/S transition); graphs indicate mean of 8 and 9 brains from one biological replicate (<bold>k</bold>). Datapoints indicate individual brains from two or three biological replicates (<bold>h</bold>). Scale bars are 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.014</object-id><label>Figure 4—figure supplement 1.</label><caption><title>G<sub>1</sub>/S and G<sub>2</sub>/M delay results in smaller brains.</title><p>(<bold>a</bold>) size (area of CNS maximum intensity projections) of pharate adult CB. (<bold>b,c</bold>) Immunostaining for Dpn (NSCs), Chinmo and Broad in the VNC of wildtype L3 larvae or larvae with NSC-specific expression of Dap and Rbf280. Arrowheads indicate Chinmo-positive NSCs. (<bold>d</bold>) Mitotic index (percentage of pH3+ cells among all Dpn+ cells) of larval VNC NSCs. (<bold>e</bold>) Correlation between mitotic index and temporal delay with linear regression and 95% confidence interval. Pearson’s correlation coefficient = −0.6058; p-value=9,55e-07. Datapoints indicate individual brains from one to two biological replicates (<bold>a,d,e</bold>). Scale bars are 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.015</object-id><label>Figure 4—figure supplement 2.</label><caption><title>AMPK deletion does not rescue the temporal patterning defect caused by OxPhos inhibition.</title><p>(<bold>a,b</bold>) Dpn (NSCs), RFP (negatively marked AMPK<sup>-/-</sup> clones) and Imp in the VNC of L3 larvae after heatshock at 0hALH. Arrowheads indicate Dpn-positive NSCs. Dashed outlines mark RFP-negative clones. RNAi is not affected by mitotic recombination and is present both in RFP-positive and RFP-negative cells. (<bold>c,d</bold>) Percentage of all Dpn-positive and either RFP-positive (AMPK<sup>+/-</sup> or AMPK<sup>+/+</sup>; red outline) or RFP-negative (AMPK<sup>-/-</sup>; black outline) NSCs in the VNC that are Imp-positive (<bold>c</bold>) or pH3-positive (<bold>d</bold>). Datapoints indicate individual brains from one biological replicate. n = 123.1 ± 3.2; 11.7 ± 1.1; 122.1 ± 4.9; 8.2 ± 1.0; 127.5 ± 4.3; 8 ± 1.7 (average ± s.e.m) NSCs per brain of the respective genotypes. Scale bars are 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig4-figsupp2-v2.tif"/></fig></fig-group><p>There is growing evidence for cross talk between mitochondrial metabolism and cell cycle progression at the G<sub>1</sub>/S transition (<xref ref-type="bibr" rid="bib45">Mandal et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Mandal et al., 2005</xref>; <xref ref-type="bibr" rid="bib49">Mitra et al., 2009</xref>; <xref ref-type="bibr" rid="bib55">Owusu-Ansah et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Schieke et al., 2008</xref>). Therefore, we assessed cell cycle stage after knockdown of complex I using Fly-Fucci (<xref ref-type="bibr" rid="bib88">Zielke et al., 2014</xref>) (<xref ref-type="fig" rid="fig4">Figure 4g</xref>). We found an increase in the number of cells in G<sub>1</sub> (26.5 ± 1.6%, n = 9 control VNCs vs. 34.9 ± 1.8%, n = 8 complex I RNAi VNCs) and at the G<sub>1</sub>/S transition (14.5 ± 2.3%, n = 9 control VNCs vs. 24.3 ± 1.7%, n = 8 complex I RNAi VNCs) (<xref ref-type="fig" rid="fig4">Figure 4i–k</xref>). Our results suggest that OxPhos dysfunction causes activation of the G<sub>1</sub>/S checkpoint and this in turn results in delayed temporal patterning of NSCs.</p><p>Activation of the G<sub>1</sub>/S checkpoint upon downregulation of OxPhos activity has been observed in various tissues in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib15">DiGregorio et al., 2001</xref>; <xref ref-type="bibr" rid="bib44">Mandal et al., 2005</xref>). In the eye disc, G<sub>1</sub>/S delay upon complex I dysfunction was caused by increased production of ROS and JNK-pathway activity, while complex IV dysfunction decreased the ATP/AMP ratio and activated the G<sub>1</sub>/S checkpoint through AMPK and p53 (<xref ref-type="bibr" rid="bib45">Mandal et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Mandal et al., 2005</xref>; <xref ref-type="bibr" rid="bib55">Owusu-Ansah et al., 2008</xref>). Our preliminary data suggest that decreasing ROS does not rescue the proliferation or temporal patterning defects of complex I or V inhibition (data not shown) and nor does knock down of AMPK or p53 (data not shown). Moreover, clones mutant for <italic>ampk</italic> in a background where all NSCs continue to express complex I or V RNAi enhanced rather than suppressed the temporal patterning defect (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a–d</xref>). Therefore, it remains to be seen which pathway activates the G<sub>1</sub>/S checkpoint in NSCs with mitochondrial dysfunction.</p></sec><sec id="s2-5"><title>OxPhos dysfunction and prolonged G<sub>1</sub>/S interfere with termination of proliferation</title><p>The adult CNS in <italic>Drosophila</italic> does not normally contain NSCs (<xref ref-type="bibr" rid="bib34">Kato et al., 2009</xref>; <xref ref-type="bibr" rid="bib62">Siegrist et al., 2010</xref>; <xref ref-type="bibr" rid="bib80">von Trotha et al., 2009</xref>). NSCs stop dividing in the first 20–30 hr after pupariation at which time they differentiate or undergo apoptosis (<xref ref-type="fig" rid="fig3">Figure 3a</xref>) (<xref ref-type="bibr" rid="bib29">Homem et al., 2014</xref>; <xref ref-type="bibr" rid="bib32">Ito and Hotta, 1992</xref>; <xref ref-type="bibr" rid="bib46">Maurange et al., 2008</xref>; <xref ref-type="bibr" rid="bib62">Siegrist et al., 2010</xref>; <xref ref-type="bibr" rid="bib75">Truman and Bate, 1988</xref>). It was previously shown that knocking down complex III or IV subunits in NSCs prevents termination of proliferation at the onset of pupal life (<xref ref-type="bibr" rid="bib29">Homem et al., 2014</xref>). The authors suggested that pupariation is accompanied by a metabolic switch from glycolysis to OxPhos that results in NSC shrinkage and cell cycle exit. Similarly, we found that when complex I or V subunits were knocked down, NSCs, identified by Dpn-expression and continued expression of GFP from a NSC-specific GAL4-driver (Worniu-GAL4), were maintained into the adult VNC and CB (<xref ref-type="fig" rid="fig5s1">Figure 5a-c—figure supplement 1a–d</xref>). Of the 133 NSCs in the larval VNC (<xref ref-type="bibr" rid="bib6">Birkholz et al., 2015</xref>; <xref ref-type="bibr" rid="bib36">Lacin and Truman, 2016</xref>), an average of 30.8 ± 3.1 and 20.2 ± 3.3 persisted into adulthood when complex I or V were inhibited respectively (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). These NSCs continued to proliferate and generate neuronal progeny (<xref ref-type="fig" rid="fig5s1">Figure 5a-c—figure supplement 1a-j</xref>). NSCs also persisted in the adult CB and VNC when the G<sub>1</sub>/S, but not G<sub>2</sub>/M, transition was delayed, independent of OxPhos dysfunction (<xref ref-type="fig" rid="fig5s1">Figure 5d-g—figure supplement 1k-n</xref>).</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.47887.016</object-id><label>Figure 5.</label><caption><title>NSCs require OxPhos for termination of proliferation.</title><p>(<bold>a–g</bold>) ElaV (neurons), GFP (NSCs, Wor-GAL4 &gt;mCD8 GFP), Dpn (NSCs) and pH3 (mitosis) in the pharate adult CB or VNC. Maximum intensity projections through the CB or VNC; dashed lines mark the outline of the CNS. (<bold>c,g</bold>) Total number of GFP-expressing NSCs in the pharate adult CB or VNC. (<bold>h,i</bold>) Dpn (NSCs), RFP (negatively marked clones) and Imp in the pharate adult CNS. Arrowheads indicate Dpn-positive NSCs. Dashed outlines mark RFP-negative clones. (<bold>j</bold>) Percentage of all Dpn-positive NSCs in the pharate adult CNS (CB and VNC) that are part of an RFP-negative clone. (<bold>k</bold>) OxPhos inhibition prevents terminal differentiation; this is rescued by timely removal of Imp. Datapoints indicate individual brains (<bold>c,g</bold>) or clones (<bold>j</bold>) from one biological replicate. Scale bars are 50 µm (<bold>a,b</bold>), 20 µm (<bold>b’</bold>) or 10 µm (h, i).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.47887.017</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Adult neurogenesis upon OxPhos knockdown and G<sub>1</sub>/S delay.</title><p>(<bold>a–d</bold>) ElaV (neurons), GFP (NSCs, Wor-GAL4 &gt;mCD8 GFP), Dpn (NSCs) and pH3 (mitosis) in the pharate adult CB (<bold>a–c</bold>) or VNC (<bold>d</bold>). Maximum intensity projections through the CB or VNC; dashed lines outline the CNS. (<bold>e–i</bold>) Dpn (NSCs), GFP (clones) and ElaV (neurons) in the pharate adult VNC. Arrowheads indicate Dpn-positive NSCs within the clone; dashed lines mark the outline of clones. Maximum intensity projections of z-stacks through the clone. (<bold>j</bold>) Number of cells per GFP-positive clone in the pharate adult VNC. Only those clones of ≥2 cells were quantified. Datapoints indicate single clones from three to five CNSs from one biological replicate; yellow datapoints indicate presence of a Dpn+ NSC in the clone. (<bold>j’</bold>) Clones from both complex I or V RNAi-expressing NSCs which still contain a Dpn+ NSC at pharate adult stage (yellow) are on average larger than those that do not (grey). (<bold>k–n</bold>) ElaV (neurons) and GFP (NSCs, Wor-GAL4 &gt;mCD8 GFP), Dpn (NSCs) and pH3 (mitosis) in the pharate adult CB. Maximum intensity projections through the CB. Scale bars are 50 µm (<bold>a–d,k–n</bold>), 20 µm (<bold>b’,c’,d’</bold>), 10 µm (<bold>k’,l</bold>) or 5 µm (<bold>e–i</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Timely cell cycle exit of <italic>Drosophila</italic> NSCs at the end of neurogenesis was shown to depend on normal progression through the larval temporal cascade (<xref ref-type="bibr" rid="bib46">Maurange et al., 2008</xref>; <xref ref-type="bibr" rid="bib86">Yang et al., 2017</xref>). We therefore asked whether the defect in termination of proliferation caused by OxPhos inhibition could be due to delayed temporal patterning during larval life, as opposed to a metabolic switch at pupariation. To test this, we restored the temporal identity in NSCs in which complex I was downregulated by removing Imp at 48 hr or 72 hr ALH. Deletion of Imp significantly decreased adult neurogenesis (<xref ref-type="fig" rid="fig5">Figure 5h–k</xref>), consistent with a direct relationship between temporal patterning defects and the adult persistence of NSCs upon OxPhos dysfunction. Together, our data indicate that the previously observed defect in termination of NSC proliferation is a consequence of the earlier temporal patterning defects caused by OxPhos dysfunction.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Significant progress has been made in identifying the signalling pathways and transcription factors that regulate stem cell transitions during brain development and homeostasis (<xref ref-type="bibr" rid="bib66">Taverna et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Tiberi et al., 2012</xref>). In contrast, our understanding of the metabolic changes that accompany, or drive, these transitions is still limited (<xref ref-type="bibr" rid="bib35">Knobloch and Jessberger, 2017</xref>). Here we show that the metabolic requirements of highly proliferative NSCs in the <italic>Drosophila</italic> brain, as well as the tumour cells they generate upon transformation, cannot be met by aerobic glycolysis alone. Instead, <italic>Drosophila</italic> NSCs require OxPhos for key aspects of their behaviour: proliferation, generation of diversity through temporal patterning, and termination of proliferation (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Respiratory activity may provide an explanation for the strong increase in ROS production that has been observed in NSCs upon hypoxia (<xref ref-type="bibr" rid="bib4">Bailey et al., 2015</xref>) and for the developmental lethality caused by CNS-specific mutation of the mitochondrial genome (<xref ref-type="bibr" rid="bib12">Chen et al., 2015</xref>). While OxPhos dysfunction affects both normal NSCs and tumour cells in the brain, inhibition of glycolysis only affects tumour growth (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) but not normal brain development (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This is reminiscent of the upregulation of aerobic glycolysis in Hipk, EGFR or PDGF/VEGF-induced tumours in the <italic>Drosophila</italic> wing disc (<xref ref-type="bibr" rid="bib18">Eichenlaub et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Wong et al., 2019</xref>). Future experiments will determine the origin and consequences of this tumour-specific reliance on glycolysis in the brain.</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.47887.018</object-id><label>Figure 6.</label><caption><title>Model of the role of OxPhos in Drosophila NSCs and tumour cells.</title><p>We propose a model, whereby highly proliferative Drosophila NSCs also rely on OxPhos for most aspects of their behaviour. In particular, the G<sub>1</sub>/S transition depends on OxPhos activity and perturbation of this transition, either directly, or indirectly through OxPhos inhibition, results in delayed temporal patterning. This in turn prevents NSCs from terminating proliferation at the appropriate time, causing neurogenesis to persist into the adult. A similar dependence on OxPhos can be seen in brain tumours, where both proliferation and differentiation require mitochondrial activity, presumably through a similar mechanism to that found in normal NSCs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-fig6-v2.tif"/></fig><p>Our results contrast with previous findings suggesting that OxPhos is dispensable during normal NSC development and in brain tumours, and is only activated at the end of neurogenesis as part of a metabolic switch to induce termination of NSC proliferation (<xref ref-type="bibr" rid="bib29">Homem et al., 2014</xref>). While our experiments do not directly address whether this metabolic switch takes place, the results provide an alternate interpretation. We find that sustained OxPhos activity throughout NSC development is required for normal temporal patterning. Prolonged expression of early temporal markers makes NSCs unresponsive to the developmental cues that govern cell cycle exit (<xref ref-type="bibr" rid="bib46">Maurange et al., 2008</xref>; <xref ref-type="bibr" rid="bib86">Yang et al., 2017</xref>) and we show that restoring temporal progression by timely depletion of the early temporal factor Imp enhances termination of proliferation in spite of continued OxPhos inhibition. Our findings thus integrate key aspects of NSC and tumour cell biology (<xref ref-type="fig" rid="fig6">Figure 6</xref>) : OxPhos-dependent proliferation is required for temporal patterning and differentiation at the G<sub>1</sub>/S transition of the cell cycle. This enables NSCs to undergo normal aging and to respond to the developmental cues that instruct termination of proliferation. Interestingly, adult neurogenesis in the subventricular zone of the mammalian brain depends on p57-induced slowing of the cell cycle during embryonic development (<xref ref-type="bibr" rid="bib20">Furutachi et al., 2015</xref>). It is not known whether p57 expression or mitochondrial dysfunction also affects the temporal identity of mammalian NSCs. Importantly, the effects we observed are specific to the G<sub>1</sub>/S transition: activation of the G<sub>2</sub>/M checkpoint did not affect temporal patterning or termination of proliferation. Our results therefore demonstrate that the size and composition of <italic>Drosophila</italic> NSC lineages are not strictly predetermined (<xref ref-type="bibr" rid="bib6">Birkholz et al., 2015</xref>) but rather controlled by both intrinsic and extrinsic factors. Single-cell sequencing data indicate that metabolic differences exist between NSCs in different regions of the brain or at different developmental stages (<xref ref-type="bibr" rid="bib14">Davie et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Genovese et al., 2018</xref>) and it will be interesting to assess whether all NSCs are similarly affected by OxPhos dysfunction and G<sub>1</sub>/S delay or whether specific lineages show stereotypical responses, as has been shown for entry into quiescence, where arrest in G<sub>2</sub> or G<sub>0</sub> is predetermined (<xref ref-type="bibr" rid="bib54">Otsuki and Brand, 2018</xref>).</p><p>Our study indicates that OxPhos might constitute a targetable metabolic vulnerability of cancer. Small molecule inhibitors of OxPhos are currently being developed and tested in clinical trials to treat various forms of cancer (<xref ref-type="bibr" rid="bib24">Gui et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Molina et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Shi et al., 2019</xref>; <xref ref-type="bibr" rid="bib83">Weinberg and Chandel, 2015</xref>). However, we find that the in vivo impact of OxPhos dysfunction is much more complex than mere inhibition of proliferation. A better understanding of the interactions between metabolism, differentiation and tumour heterogeneity in vivo has the potential to uncover novel therapeutic approaches.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species)</th><th valign="top">Designation</th><th valign="top">Source <break/>or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">mCherry-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_35785">BDSC_35785</ext-link></td><td valign="top">Control RNAi</td></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">w<sup>1118</sup>;+;+</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_3605">BDSC_3605</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">ND75-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_33911">BDSC_33911</ext-link></td><td valign="top">Complex I RNAi</td></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Blw-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_28059">BDSC_28059</ext-link></td><td valign="top">Complex V RNAi</td></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Pros-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_42538">BDSC_42538</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Brat-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_28590">BDSC_28590</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">ND42-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_32998">BDSC_32998</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">ND51-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_36701">BDSC_36701</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Blw-RNAi-KK</td><td valign="top">VDRC</td><td valign="top">34663</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">ATPsynβ-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_28056">BDSC_28056</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">ATPsynγ-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_28723">BDSC_28723</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">ATPsynO-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_43265">BDSC_43265</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">PFK-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_34336">BDSC_34336</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Aldolase-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_26301">BDSC_26301</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">PyK-TRIP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_35218">BDSC_35218</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">PGK-RNAi-KK</td><td valign="top">VDRC</td><td valign="top">110081</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UASp-EGFP-Myt1</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_65393">BDSC_65393</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UASt-dWee1</td><td valign="top">(<xref ref-type="bibr" rid="bib58">Price et al., 2002</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/12072468">12072468</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UASt-Dap</td><td valign="top">(<xref ref-type="bibr" rid="bib38">Lane et al., 1996</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/8980229">8980229</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UAS-Rbf-280</td><td valign="top">(<xref ref-type="bibr" rid="bib16">Duman-Scheel et al., 2002</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/12015606">12015606</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UASt-aPKC.CAAXWT</td><td valign="top">(<xref ref-type="bibr" rid="bib40">Lee et al., 2006</xref>; <xref ref-type="bibr" rid="bib63">Sotillos et al., 2004</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16357871">16357871</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15302858">15302858</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UAS-mito-HA-GFP,e1</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_8443">BDSC_8443</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UAS-AT1.03-NL on III</td><td valign="top">(<xref ref-type="bibr" rid="bib76">Tsuyama et al., 2013</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23875533">23875533</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UAS-AT1.03-RK on III</td><td valign="top">(<xref ref-type="bibr" rid="bib76">Tsuyama et al., 2013</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/23875533">23875533</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">UAS-GFP-E2F1.1–230, UAS-mRFP1-NLS-CycB.1–266</td><td valign="top">(<xref ref-type="bibr" rid="bib88">Zielke et al., 2014</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24726363">24726363</ext-link></td><td valign="top"/><td valign="top">Fly FUCCI</td></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Worniu-GAL4 on II</td><td valign="top">(<xref ref-type="bibr" rid="bib2">Albertson et al., 2004</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15536119">15536119</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Cas::GFP FlyFos line</td><td valign="top">VDRC</td><td valign="top">318476</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Ubi-FRT-Stop-FRT-GFP</td><td valign="top">BDSC</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/BDSC_32251">BDSC_32251</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Imp<sup>8</sup></td><td valign="top">(<xref ref-type="bibr" rid="bib52">Munro et al., 2006</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16476777">16476777</ext-link></td><td valign="top"/><td valign="top">Imp mutant</td></tr><tr><td valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td valign="top">Ampkα<sup>3</sup></td><td valign="top">(<xref ref-type="bibr" rid="bib25">Haack et al., 2013</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24337115">24337115</ext-link></td><td valign="top"/><td valign="top">AMPK mutant</td></tr><tr><td valign="top">Antibody</td><td valign="top">rat anti-PH3 (monoclonal)</td><td valign="top">Abcam</td><td valign="top">ab10543 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2295065">AB_2295065</ext-link></td><td valign="top">IF, 1/500</td></tr><tr><td valign="top">Antibody</td><td valign="top">rabbit anti-PH3 (polyclonal)</td><td valign="top">Merck Millipore</td><td valign="top">06–570 RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_310177">AB_310177</ext-link></td><td valign="top">IF, 1/500</td></tr><tr><td valign="top">Antibody</td><td valign="top">guinea pig anti-Dpn (polyclonal)</td><td valign="top">James Skeath</td><td valign="top"/><td valign="top">IF, 1/10,000</td></tr><tr><td valign="top">Antibody</td><td valign="top">rabbit anti-Imp (polyclonal)</td><td valign="top">(<xref ref-type="bibr" rid="bib22">Geng and Macdonald, 2006</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17030623">17030623</ext-link></td><td valign="top"/><td valign="top">IF, 1/600</td></tr><tr><td valign="top">Antibody</td><td valign="top">guinea pig anti-Syp (polyclonal)</td><td valign="top">(<xref ref-type="bibr" rid="bib48">McDermott et al., 2012</xref>) PMID: <break/><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/?term=23213441">23213441</ext-link></td><td valign="top"/><td valign="top">IF, 1/1000</td></tr><tr><td valign="top">Antibody</td><td valign="top">chicken anti-GFP (polyclonal)</td><td valign="top">Abcam</td><td valign="top">ab13970 RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_300798">AB_300798</ext-link></td><td valign="top">IF, 1/2000</td></tr><tr><td valign="top">Antibody</td><td valign="top">rat anti-Mira (polyclonal)</td><td valign="top">Chris Doe</td><td valign="top"/><td valign="top">IF, 1/500</td></tr><tr><td valign="top">Antibody</td><td valign="top">rat anti-Chinmo (polyclonal)</td><td valign="top">(<xref ref-type="bibr" rid="bib85">Wu et al., 2012</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22814608">22814608</ext-link></td><td valign="top"/><td valign="top">IF, 1/500</td></tr><tr><td valign="top">Antibody</td><td valign="top">mouse anti-Broad (monoclonal)</td><td valign="top">DSHB</td><td valign="top">25E9.07</td><td valign="top">IF, 1/100</td></tr><tr><td valign="top">Antibody</td><td valign="top">rabbit anti-RFP (polyclonal)</td><td valign="top">Abcam</td><td valign="top">ab62341 RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_945213">AB_945213</ext-link></td><td valign="top">IF, 1/500</td></tr><tr><td valign="top">Antibody</td><td valign="top">rat anti-ElaV (monoclonal)</td><td valign="top">DSHB</td><td valign="top">7E8A10</td><td valign="top">IF, 1/100</td></tr><tr><td valign="top">Antibody</td><td valign="top">mouse anti-Sevenup (polyclonal)</td><td valign="top">(<xref ref-type="bibr" rid="bib33">Kanai et al., 2005</xref>) PMID: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15691762">15691762</ext-link></td><td valign="top"/><td valign="top">IF, 1/200</td></tr><tr><td valign="top">Antibody</td><td valign="top">mouse anti-ATPsynα (monoclonal)</td><td valign="top">Abcam</td><td valign="top">ab14748 RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_301447">AB_301447</ext-link></td><td valign="top">IF, 1/100</td></tr><tr><td valign="top">Antibody</td><td valign="top">GFP-booster Atto647N</td><td valign="top">Chromotek</td><td valign="top">gba647n RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2629215">AB_2629215</ext-link></td><td valign="top">IF, 1/500 for STED</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">ApopTag Red In Situ Apoptosis Detection kit</td><td valign="top">Merkc Millipore</td><td valign="top">S7165</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Click-iT EdU Alexa Fluor 647 Imaging Kit</td><td valign="top">Invitrogen</td><td valign="top">C10340</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">2-deoxyglucose</td><td valign="top">Sigma</td><td valign="top">D8375</td><td valign="top">200 mM final concentration</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Fly husbandry</title><p><italic>Drosophila melanogaster</italic> were reared in cages at 25°C. For most experiments, embryos were collected on food plates for 3 hr and transferred to 29°C until analysis. Unless indicated otherwise, larvae were matched for developmental timing at wandering third instar (L3). For time-course experiments, embryos were collected on yeasted apple juice plates and larvae were transferred to a fresh yeasted food plate within 2 hr of hatching (designated 0 hr ALH) and grown at 25°C until the desired stage. For clonal analysis, embryos and larvae were grown at 25°C and heat-shocked when indicated for 20 min in a 37°C water bath.</p></sec><sec id="s4-2"><title>Fly stocks</title><p>The following stocks were used: mCherry-TRIP (Bl#35785) was used as control RNAi and w<sup>1118</sup>;+;+ as control. Unless otherwise indicated all Complex I RNAi data are from ND75-TRIP (NDUFS1; Bl#33911)(<xref ref-type="bibr" rid="bib56">Owusu-Ansah et al., 2013</xref>) and all Complex V RNAi data from Blw-TRIP (ATPsynα; Bl#28059)(<xref ref-type="bibr" rid="bib68">Teixeira et al., 2015</xref>). The other UAS-lines used were: Pros-TRIP (Bl#42538); Brat-TRIP (Bl#28590); ND42-TRIP (Bl#32998)(<xref ref-type="bibr" rid="bib21">Garcia et al., 2017</xref>); ND51-TRIP (Bl#36701) (<xref ref-type="bibr" rid="bib21">Garcia et al., 2017</xref>); Blw-RNAi-KK (VDRC#34663) (<xref ref-type="bibr" rid="bib68">Teixeira et al., 2015</xref>); ATPsynγ-TRIP (Bl#28723) (<xref ref-type="bibr" rid="bib68">Teixeira et al., 2015</xref>); PFK-TRIP (Bl#34336); Aldolase-TRIP (Bl#26301); PyK-TRIP (Bl#35218); PGK-RNAi-KK (VDRC#110081); UASp-EGFP-Myt1 (Bl#65393); UASt-dWee1 (<xref ref-type="bibr" rid="bib58">Price et al., 2002</xref>); UASt-Dap (<xref ref-type="bibr" rid="bib38">Lane et al., 1996</xref>); UAS-Rbf-280 (<xref ref-type="bibr" rid="bib16">Duman-Scheel et al., 2002</xref>); UASt-aPKC.CAAXWT (<xref ref-type="bibr" rid="bib40">Lee et al., 2006</xref>; <xref ref-type="bibr" rid="bib63">Sotillos et al., 2004</xref>); UAS-mito-HA-GFP,e1 (Bl#8443); UAS-AT1.03-NL and UAS-AT1.03-RK on III (<xref ref-type="bibr" rid="bib76">Tsuyama et al., 2013</xref>); Fly-FUCCI (<xref ref-type="bibr" rid="bib88">Zielke et al., 2014</xref>) was UAS-GFP-E2F1.1–230, UAS-mRFP1-NLS-CycB.1–266. All RNAis against OxPhos or glycolysis components caused developmental lethality upon ubiquitous expression with Tubulin-GAL4 on III. The GAL4-driver used throughout the study was Worniu-GAL4 on II (<xref ref-type="bibr" rid="bib2">Albertson et al., 2004</xref>), either on its own, or recombined with UAS-mCD8-GFP on II and Tub-GAL80<sup>ts</sup> on III. Castor was visualised with Cas::GFP FlyFos line (VDRC#318476). The genotypes for mitotic recombination clones (<xref ref-type="fig" rid="fig3">Figure 3h</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2d–f</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>; <xref ref-type="fig" rid="fig5">Figure 5h–j</xref>) were as follows: yw,FRT19a (control), yw,Imp<sup>8</sup>,FRT19a (Imp-mutant; <xref ref-type="bibr" rid="bib52">Munro et al., 2006</xref>) or yw,Ampkα<sup>3</sup>,FRT19a (AMPK-mutant; <xref ref-type="bibr" rid="bib25">Haack et al., 2013</xref>)/yw,hsflp,ubi-RFP,FRT19a;Wor-Gal4;+ or ND75-TRIP/+ or Blw-TRIP/+. This resulted in NSC lineages which were randomly marked upon heat-shock by mitotic recombination, whereby all NSCs in the CNS continued to express the RNAi. The genotypes for flip-out clones (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1e–j</xref>) were as follows: yw,hsflp/+;Wor-Gal4;Ubi-FRT-Stop-FRT-GFP (from Bl#32251) (<xref ref-type="bibr" rid="bib19">Evans et al., 2009</xref>)/+ or ND75-TRIP or Blw-TRIP.</p></sec><sec id="s4-3"><title>Immunostaining, EdU and TUNEL</title><p>Larval brains were dissected in PBS with 0.3% Triton (PBST), fixed in 4% formaldehyde/PBST for 20 min and washed three times in PBST. For EdU incorporation, freshly dissected brains were immersed in PBS containing 200 ug/ml EdU for 15 min, rinsed twice in PBS and then fixed. EdU detection was performed using a Click-iT EdU Alexa Fluor 647 Imaging Kit (Invitrogen C10340) according to the manufacturer’s instructions. For immunostaining, brains were incubated with primary antibodies in PBST overnight at 4°C, washed with PBST, incubated with Alexa Fluor-conjugated secondary antibodies (Life Technologies) or a GFP-nanobody coupled to Atto647N (Chromotek gba647n) diluted 1/500 in PBST overnight at 4°C and washed with PBST. Brains were mounted in Prolong Diamond Antifade Mountant (Invitrogen). TUNEL staining was done using the ApopTag Red In Situ Apoptosis Detection Kit (Merck Millipore S7165) according to the manufacturer’s instructions.</p></sec><sec id="s4-4"><title>Antibodies</title><p>The following primary antibodies were used: rat anti-PH3 (1/500, Abcam ab10543); rabbit anti-PH3 (1/500, Merck Millipore, 06–570); guinea pig anti-Dpn (1/10,000, gift of James Skeath); rabbit anti-Imp (1/600, gift of Paul MacDonald; <xref ref-type="bibr" rid="bib22">Geng and Macdonald, 2006</xref>); guinea pig anti-Syp (1/1000, gift of Ilan Davis; <xref ref-type="bibr" rid="bib48">McDermott et al., 2012</xref>); chicken anti-GFP (1/2000, Abcam ab13970), rat anti-Mira (1/500, gift of Chris Doe); rat anti-Chinmo (1/500, gift of Nicholas Sokol; <xref ref-type="bibr" rid="bib85">Wu et al., 2012</xref>); mouse anti-Broad (1/100, DSHB 25E9.07); rabbit anti-RFP (1/500, Abcam ab62341); rat anti-ElaV (1/100, DSHB 7E8A10); mouse anti-Sevenup (1/200, gift of Yasushi Hiromi; <xref ref-type="bibr" rid="bib33">Kanai et al., 2005</xref>); mouse anti-ATPsynα (1/100, Abcam ab14748).</p></sec><sec id="s4-5"><title>Imaging and image processing</title><p>Fluorescent images were acquired using a Leica SP8 confocal microscope and analysed using ImageJ. For the larval CNS, we imaged the thoracic segments of the VNC from the ventral side until the neuropil, or the ventral regions of the CB; for the adult CNS, the entire VNC or CB was imaged. All images are single sections, unless indicated otherwise. For live imaging, third instar larval brains were dissected at room temperature in Schneider’s insect medium (Sigma S0146), mounted in Schneider’s medium with 10% FBS on low 35 mm Ibitreat dishes (Ibidi 80136) and imaged on an inverted Leica SP8 confocal microscope at room temperature. Z-stacks of the ventral side of the thoracic VNC were made at the indicated intervals for 3 hr. For live in vivo ATP measurements with an ATP FRET sensor for <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib31">Imamura et al., 2009</xref>; <xref ref-type="bibr" rid="bib76">Tsuyama et al., 2013</xref>), confocal settings were as follows: 405 nm excitation and simultaneous detection at 445–490 nm (CFP) and 530–760 nm (FRET); 2-DG (Sigma D8375) was added to the medium to a final concentration of 200 mM. Ratios were calculated for mean FRET/CFP intensity per NSC. Stimulated emission depletion (STED) super-resolution imaging was performed on a custom STED microscope as described in <xref ref-type="bibr" rid="bib74">Trovisco et al. (2016)</xref> with a 100x UPlanSApo 1.35 NA silicone oil immersion objective lens (Olympus, Japan) over a region of 20 μm<sup>2</sup> (1024 × 1024 pixels). Images were processed using ImageJ. Timestamps were generated with a custom-built OverTime ImageJ plugin (Richard Butler). Figures were compiled in Adobe Illustrator.</p></sec><sec id="s4-6"><title>Quantifications and statistical analysis</title><p>For quantification of NSCs, Dpn- or Mira-positive NSC on the ventral side of the thoracic VNC at the indicated stage were counted. For TUNEL-staining all TUNEL-positive cells were quantified throughout the entire thickness of the thoracic VNC. To quantify adult NSCs, all GFP-positive lineages were counted throughout the entire VNC or CB; in the control CB, GFP perdures until pharate adult stage in eight mushroom body lineages, which terminate proliferation only at the end of pupal life. To quantify adult NSCs upon Imp-mutation (<xref ref-type="fig" rid="fig5">Figure 5j</xref>), all Dpn-positive cells were counted in the VNC or CB. Mitotic index is the number of pH3-positive cells among Dpn-positive cells. For quantification of tumour mitotic index, over 200 Dpn-positive cells were quantified in each thoracic VNC. For brain size, the area of CNS maximum projections was measured.</p><p>Graphs were generated in R or Excel. Box-and-whisker plots depict median, interquartile range (box) and 1.5IQR below and above the first and third quartiles respectively (whiskers). Bar graphs, line graphs and values in the text indicate mean ± s.e.m. Datapoints indicate the value of individual VNCs or CBs, apart from <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1j</xref> where datapoints depict individual clones. One biological replicate is defined as the result of one parental cross.</p><p>Statistical tests were performed in R. All datasets were first checked for normal distribution with a Shapiro-Wilk test, and then ANOVA was performed with a post-hoc Tukey test. When data were not normal distributed, Kruskal-Wallis test was performed with post-hoc Dunn test and Bonferroni adjustment for multiple comparisons. For time course experiments (<xref ref-type="fig" rid="fig3s1">Figure 3e—figure supplement 1h</xref>), the two conditions at individual time-points were compared with a two-sided Mann-Whitney U test. ATP measurements (AT1.03-NL) were normalised for each NSC to t = 0 when 2-DG was added to the medium, and to the mean values from VNCs that expressed an ATP-insensitive sensor (AT1.03-RK) and were imaged in the same experiment. Modelling of the dynamics of ATP levels was done in R, based on the assumption of exponential decay. Significance is shown compared to control samples, unless indicated otherwise, with the following symbols: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; n.s. p≥0.05.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank C Doe, I Davis, Y Hiromi, P MacDonald, J Skeath, N Sokol for antisera, and D St Johnston, T Uemura, the Bloomington Drosophila Stock Centre and Vienna Drosophila Resource Centre for Drosophila stocks. We thank R Butler (Gurdon Institute Imaging Facility) for the OverTime Fiji plugin, G Sirinakis for help with super-resolution imaging, R Krautz for statistical modelling and Y Bellaiche, W Staels, F Munoz-Martinez, PF Chinnery and members of the Brand lab for discussion and comments on the manuscript. This work was funded by Wellcome Trust Senior Investigator Award (103792) and Royal Society Darwin Trust Research Professorship to AHB. JvdA was supported by EMBO Long-term Fellowship (ALTF 1600_2014) and Wellcome Trust Postdoctoral Training Fellowship for Clinicians (105839). AHB acknowledges core funding to the Gurdon Institute from the Wellcome Trust (092096) and CRUK (C6946/A14492).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Formal analysis, Funding acquisition, Validation, Investigation, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.47887.019</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-47887-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agathocleous</surname> <given-names>M</given-names></name><name><surname>Love</surname> <given-names>NK</given-names></name><name><surname>Randlett</surname> <given-names>O</given-names></name><name><surname>Harris</surname> <given-names>JJ</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Murray</surname> <given-names>AJ</given-names></name><name><surname>Harris</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Metabolic differentiation in the embryonic retina</article-title><source>Nature Cell Biology</source><volume>14</volume><fpage>859</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1038/ncb2531</pub-id><pub-id pub-id-type="pmid">22750943</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albertson</surname> <given-names>R</given-names></name><name><surname>Chabu</surname> <given-names>C</given-names></name><name><surname>Sheehan</surname> <given-names>A</given-names></name><name><surname>Doe</surname> <given-names>CQ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Scribble protein domain mapping reveals a multistep localization mechanism and domains necessary for establishing cortical polarity</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>6061</fpage><lpage>6070</lpage><pub-id pub-id-type="doi">10.1242/jcs.01525</pub-id><pub-id pub-id-type="pmid">15536119</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzarelli</surname> <given-names>R</given-names></name><name><surname>Simons</surname> <given-names>BD</given-names></name><name><surname>Philpott</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The developmental origin of brain tumours: a cellular and molecular framework</article-title><source>Development</source><volume>145</volume><elocation-id>dev162693</elocation-id><pub-id pub-id-type="doi">10.1242/dev.162693</pub-id><pub-id pub-id-type="pmid">29759978</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname> <given-names>AP</given-names></name><name><surname>Koster</surname> <given-names>G</given-names></name><name><surname>Guillermier</surname> <given-names>C</given-names></name><name><surname>Hirst</surname> <given-names>EM</given-names></name><name><surname>MacRae</surname> <given-names>JI</given-names></name><name><surname>Lechene</surname> <given-names>CP</given-names></name><name><surname>Postle</surname> <given-names>AD</given-names></name><name><surname>Gould</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Antioxidant role for lipid droplets in a stem cell niche of Drosophila</article-title><source>Cell</source><volume>163</volume><fpage>340</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.09.020</pub-id><pub-id pub-id-type="pmid">26451484</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckervordersandforth</surname> <given-names>R</given-names></name><name><surname>Ebert</surname> <given-names>B</given-names></name><name><surname>Schäffner</surname> <given-names>I</given-names></name><name><surname>Moss</surname> <given-names>J</given-names></name><name><surname>Fiebig</surname> <given-names>C</given-names></name><name><surname>Shin</surname> <given-names>J</given-names></name><name><surname>Moore</surname> <given-names>DL</given-names></name><name><surname>Ghosh</surname> <given-names>L</given-names></name><name><surname>Trinchero</surname> <given-names>MF</given-names></name><name><surname>Stockburger</surname> <given-names>C</given-names></name><name><surname>Friedland</surname> <given-names>K</given-names></name><name><surname>Steib</surname> <given-names>K</given-names></name><name><surname>von Wittgenstein</surname> <given-names>J</given-names></name><name><surname>Keiner</surname> <given-names>S</given-names></name><name><surname>Redecker</surname> <given-names>C</given-names></name><name><surname>Hölter</surname> <given-names>SM</given-names></name><name><surname>Xiang</surname> <given-names>W</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Jagasia</surname> <given-names>R</given-names></name><name><surname>Schinder</surname> <given-names>AF</given-names></name><name><surname>Ming</surname> <given-names>GL</given-names></name><name><surname>Toni</surname> <given-names>N</given-names></name><name><surname>Jessberger</surname> <given-names>S</given-names></name><name><surname>Song</surname> <given-names>H</given-names></name><name><surname>Lie</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Role of mitochondrial metabolism in the control of early lineage progression and aging phenotypes in adult hippocampal neurogenesis</article-title><source>Neuron</source><volume>93</volume><fpage>560</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.12.017</pub-id><pub-id pub-id-type="pmid">28111078</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkholz</surname> <given-names>O</given-names></name><name><surname>Rickert</surname> <given-names>C</given-names></name><name><surname>Nowak</surname> <given-names>J</given-names></name><name><surname>Coban</surname> <given-names>IC</given-names></name><name><surname>Technau</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Bridging the gap between postembryonic cell lineages and identified embryonic neuroblasts in the ventral nerve cord of Drosophila Melanogaster</article-title><source>Biology Open</source><volume>4</volume><fpage>420</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1242/bio.201411072</pub-id><pub-id pub-id-type="pmid">25819843</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birsoy</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>WW</given-names></name><name><surname>Freinkman</surname> <given-names>E</given-names></name><name><surname>Abu-Remaileh</surname> <given-names>M</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis</article-title><source>Cell</source><volume>162</volume><fpage>540</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.016</pub-id><pub-id pub-id-type="pmid">26232224</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname> <given-names>SK</given-names></name><name><surname>Rolland</surname> <given-names>V</given-names></name><name><surname>Betschinger</surname> <given-names>J</given-names></name><name><surname>Kinsey</surname> <given-names>KA</given-names></name><name><surname>Emery</surname> <given-names>G</given-names></name><name><surname>Knoblich</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The tumor suppressors brat and numb regulate transit-amplifying neuroblast lineages in Drosophila</article-title><source>Developmental Cell</source><volume>14</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2008.03.004</pub-id><pub-id pub-id-type="pmid">18342578</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname> <given-names>AH</given-names></name><name><surname>Livesey</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neural stem cell biology in vertebrates and invertebrates: more alike than different?</article-title><source>Neuron</source><volume>70</volume><fpage>719</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.016</pub-id><pub-id pub-id-type="pmid">21609827</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caussinus</surname> <given-names>E</given-names></name><name><surname>Gonzalez</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster</article-title><source>Nature genetics</source><volume>37</volume><fpage>1125</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1038/ng1632</pub-id><pub-id pub-id-type="pmid">16142234</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandel</surname> <given-names>NS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondria as signaling organelles</article-title><source>BMC Biology</source><volume>12</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7007-12-34</pub-id><pub-id pub-id-type="pmid">24884669</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Qi</surname> <given-names>Y</given-names></name><name><surname>French</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>G</given-names></name><name><surname>Covian Garcia</surname> <given-names>R</given-names></name><name><surname>Balaban</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic mosaic analysis of a deleterious mitochondrial DNA mutation in <italic>Drosophila</italic> reveals novel aspects of mitochondrial regulation and function</article-title><source>Molecular Biology of the Cell</source><volume>26</volume><fpage>674</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1091/mbc.E14-11-1513</pub-id><pub-id pub-id-type="pmid">25501370</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choksi</surname> <given-names>SP</given-names></name><name><surname>Southall</surname> <given-names>TD</given-names></name><name><surname>Bossing</surname> <given-names>T</given-names></name><name><surname>Edoff</surname> <given-names>K</given-names></name><name><surname>de Wit</surname> <given-names>E</given-names></name><name><surname>Fischer</surname> <given-names>BE</given-names></name><name><surname>van Steensel</surname> <given-names>B</given-names></name><name><surname>Micklem</surname> <given-names>G</given-names></name><name><surname>Brand</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Prospero acts as a binary switch between self-renewal and differentiation in Drosophila neural stem cells</article-title><source>Developmental Cell</source><volume>11</volume><fpage>775</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.09.015</pub-id><pub-id pub-id-type="pmid">17141154</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davie</surname> <given-names>K</given-names></name><name><surname>Janssens</surname> <given-names>J</given-names></name><name><surname>Koldere</surname> <given-names>D</given-names></name><name><surname>De Waegeneer</surname> <given-names>M</given-names></name><name><surname>Pech</surname> <given-names>U</given-names></name><name><surname>Kreft</surname> <given-names>Ł</given-names></name><name><surname>Aibar</surname> <given-names>S</given-names></name><name><surname>Makhzami</surname> <given-names>S</given-names></name><name><surname>Christiaens</surname> <given-names>V</given-names></name><name><surname>Bravo González-Blas</surname> <given-names>C</given-names></name><name><surname>Poovathingal</surname> <given-names>S</given-names></name><name><surname>Hulselmans</surname> <given-names>G</given-names></name><name><surname>Spanier</surname> <given-names>KI</given-names></name><name><surname>Moerman</surname> <given-names>T</given-names></name><name><surname>Vanspauwen</surname> <given-names>B</given-names></name><name><surname>Geurs</surname> <given-names>S</given-names></name><name><surname>Voet</surname> <given-names>T</given-names></name><name><surname>Lammertyn</surname> <given-names>J</given-names></name><name><surname>Thienpont</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Konstantinides</surname> <given-names>N</given-names></name><name><surname>Fiers</surname> <given-names>M</given-names></name><name><surname>Verstreken</surname> <given-names>P</given-names></name><name><surname>Aerts</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Single-Cell transcriptome atlas of the aging Drosophila brain</article-title><source>Cell</source><volume>174</volume><fpage>982</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.057</pub-id><pub-id pub-id-type="pmid">29909982</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiGregorio</surname> <given-names>PJ</given-names></name><name><surname>Ubersax</surname> <given-names>JA</given-names></name><name><surname>O'Farrell</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Hypoxia and nitric oxide induce a rapid, reversible cell cycle arrest of the Drosophila syncytial divisions</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>1930</fpage><lpage>1937</lpage><pub-id pub-id-type="doi">10.1074/jbc.M003911200</pub-id><pub-id pub-id-type="pmid">11054409</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman-Scheel</surname> <given-names>M</given-names></name><name><surname>Weng</surname> <given-names>L</given-names></name><name><surname>Xin</surname> <given-names>S</given-names></name><name><surname>Du</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E</article-title><source>Nature</source><volume>417</volume><fpage>299</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/417299a</pub-id><pub-id pub-id-type="pmid">12015606</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duvezin-Caubet</surname> <given-names>S</given-names></name><name><surname>Jagasia</surname> <given-names>R</given-names></name><name><surname>Wagener</surname> <given-names>J</given-names></name><name><surname>Hofmann</surname> <given-names>S</given-names></name><name><surname>Trifunovic</surname> <given-names>A</given-names></name><name><surname>Hansson</surname> <given-names>A</given-names></name><name><surname>Chomyn</surname> <given-names>A</given-names></name><name><surname>Bauer</surname> <given-names>MF</given-names></name><name><surname>Attardi</surname> <given-names>G</given-names></name><name><surname>Larsson</surname> <given-names>NG</given-names></name><name><surname>Neupert</surname> <given-names>W</given-names></name><name><surname>Reichert</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>37972</fpage><lpage>37979</lpage><pub-id pub-id-type="doi">10.1074/jbc.M606059200</pub-id><pub-id pub-id-type="pmid">17003040</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichenlaub</surname> <given-names>T</given-names></name><name><surname>Villadsen</surname> <given-names>R</given-names></name><name><surname>Freitas</surname> <given-names>FCP</given-names></name><name><surname>Andrejeva</surname> <given-names>D</given-names></name><name><surname>Aldana</surname> <given-names>BI</given-names></name><name><surname>Nguyen</surname> <given-names>HT</given-names></name><name><surname>Petersen</surname> <given-names>OW</given-names></name><name><surname>Gorodkin</surname> <given-names>J</given-names></name><name><surname>Herranz</surname> <given-names>H</given-names></name><name><surname>Cohen</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Warburg effect metabolism drives neoplasia in a Drosophila genetic model of epithelial Cancer</article-title><source>Current Biology</source><volume>28</volume><fpage>3220</fpage><lpage>3228</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.08.035</pub-id><pub-id pub-id-type="pmid">30293715</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>CJ</given-names></name><name><surname>Olson</surname> <given-names>JM</given-names></name><name><surname>Ngo</surname> <given-names>KT</given-names></name><name><surname>Kim</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>NE</given-names></name><name><surname>Kuoy</surname> <given-names>E</given-names></name><name><surname>Patananan</surname> <given-names>AN</given-names></name><name><surname>Sitz</surname> <given-names>D</given-names></name><name><surname>Tran</surname> <given-names>P</given-names></name><name><surname>Do</surname> <given-names>MT</given-names></name><name><surname>Yackle</surname> <given-names>K</given-names></name><name><surname>Cespedes</surname> <given-names>A</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Call</surname> <given-names>GB</given-names></name><name><surname>Banerjee</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>G-TRACE: rapid Gal4-based cell lineage analysis in Drosophila</article-title><source>Nature Methods</source><volume>6</volume><fpage>603</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1356</pub-id><pub-id pub-id-type="pmid">19633663</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furutachi</surname> <given-names>S</given-names></name><name><surname>Miya</surname> <given-names>H</given-names></name><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Kawai</surname> <given-names>H</given-names></name><name><surname>Yamasaki</surname> <given-names>N</given-names></name><name><surname>Harada</surname> <given-names>Y</given-names></name><name><surname>Imayoshi</surname> <given-names>I</given-names></name><name><surname>Nelson</surname> <given-names>M</given-names></name><name><surname>Nakayama</surname> <given-names>KI</given-names></name><name><surname>Hirabayashi</surname> <given-names>Y</given-names></name><name><surname>Gotoh</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Slowly dividing neural progenitors are an embryonic origin of adult neural stem cells</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>657</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1038/nn.3989</pub-id><pub-id pub-id-type="pmid">25821910</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname> <given-names>CJ</given-names></name><name><surname>Khajeh</surname> <given-names>J</given-names></name><name><surname>Coulanges</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>EI</given-names></name><name><surname>Owusu-Ansah</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulation of Mitochondrial Complex I Biogenesis in Drosophila Flight Muscles</article-title><source>Cell reports</source><volume>20</volume><fpage>264</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.015</pub-id><pub-id pub-id-type="pmid">28683319</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname> <given-names>C</given-names></name><name><surname>Macdonald</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Imp associates with squid and Hrp48 and contributes to localized expression of gurken in the oocyte</article-title><source>Molecular and cellular biology</source><volume>26</volume><fpage>9508</fpage><lpage>9516</lpage><pub-id pub-id-type="doi">10.1128/MCB.01136-06</pub-id><pub-id pub-id-type="pmid">17030623</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Genovese</surname> <given-names>S</given-names></name><name><surname>Clement</surname> <given-names>R</given-names></name><name><surname>Gaultier</surname> <given-names>C</given-names></name><name><surname>Besse</surname> <given-names>F</given-names></name><name><surname>Narbonne-Reveau</surname> <given-names>K</given-names></name><name><surname>Daian</surname> <given-names>F</given-names></name><name><surname>Foppolo</surname> <given-names>S</given-names></name><name><surname>Luis</surname> <given-names>NM</given-names></name><name><surname>Maurange</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cooption of antagonistic RNA-binding proteins establishes cell hierarchy in Drosophila neuro-developmental tumors</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/353508</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gui</surname> <given-names>DY</given-names></name><name><surname>Sullivan</surname> <given-names>LB</given-names></name><name><surname>Luengo</surname> <given-names>A</given-names></name><name><surname>Hosios</surname> <given-names>AM</given-names></name><name><surname>Bush</surname> <given-names>LN</given-names></name><name><surname>Gitego</surname> <given-names>N</given-names></name><name><surname>Davidson</surname> <given-names>SM</given-names></name><name><surname>Freinkman</surname> <given-names>E</given-names></name><name><surname>Thomas</surname> <given-names>CJ</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines Cancer cell sensitivity to metformin</article-title><source>Cell Metabolism</source><volume>24</volume><fpage>716</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.006</pub-id><pub-id pub-id-type="pmid">27746050</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haack</surname> <given-names>T</given-names></name><name><surname>Bergstralh</surname> <given-names>DT</given-names></name><name><surname>St Johnston</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Damage to the Drosophila follicle cell epithelium produces &quot;false clones&quot; with apparent polarity phenotypes</article-title><source>Biology Open</source><volume>2</volume><fpage>1313</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1242/bio.20134671</pub-id><pub-id pub-id-type="pmid">24337115</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakes</surname> <given-names>AE</given-names></name><name><surname>Brand</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neural stem cell dynamics: the development of brain tumours</article-title><source>Current Opinion in Cell Biology</source><volume>60</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2019.06.001</pub-id><pub-id pub-id-type="pmid">31330360</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>CN</given-names></name><name><surname>Klein-Flügge</surname> <given-names>MC</given-names></name><name><surname>Howarth</surname> <given-names>C</given-names></name><name><surname>Attwell</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>8940</fpage><lpage>8951</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0026-12.2012</pub-id><pub-id pub-id-type="pmid">22745494</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermle</surname> <given-names>T</given-names></name><name><surname>Braun</surname> <given-names>DA</given-names></name><name><surname>Helmstädter</surname> <given-names>M</given-names></name><name><surname>Huber</surname> <given-names>TB</given-names></name><name><surname>Hildebrandt</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Modeling monogenic human nephrotic syndrome in the <italic>Drosophila</italic> Garland Cell Nephrocyte</article-title><source>Journal of the American Society of Nephrology</source><volume>28</volume><fpage>1521</fpage><lpage>1533</lpage><pub-id pub-id-type="doi">10.1681/ASN.2016050517</pub-id><pub-id pub-id-type="pmid">27932481</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homem</surname> <given-names>CCF</given-names></name><name><surname>Steinmann</surname> <given-names>V</given-names></name><name><surname>Burkard</surname> <given-names>TR</given-names></name><name><surname>Jais</surname> <given-names>A</given-names></name><name><surname>Esterbauer</surname> <given-names>H</given-names></name><name><surname>Knoblich</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ecdysone and mediator change energy metabolism to terminate proliferation in Drosophila neural stem cells</article-title><source>Cell</source><volume>158</volume><fpage>874</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.06.024</pub-id><pub-id pub-id-type="pmid">25126791</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name><name><surname>Bielas</surname> <given-names>JH</given-names></name><name><surname>O'Sullivan</surname> <given-names>J</given-names></name><name><surname>Sheahan</surname> <given-names>K</given-names></name><name><surname>Cantley</surname> <given-names>LC</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name><name><surname>Vitkup</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Heterogeneity of tumor-induced gene expression changes in the human metabolic network</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>522</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1038/nbt.2530</pub-id><pub-id pub-id-type="pmid">23604282</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname> <given-names>H</given-names></name><name><surname>Nhat</surname> <given-names>KP</given-names></name><name><surname>Togawa</surname> <given-names>H</given-names></name><name><surname>Saito</surname> <given-names>K</given-names></name><name><surname>Iino</surname> <given-names>R</given-names></name><name><surname>Kato-Yamada</surname> <given-names>Y</given-names></name><name><surname>Nagai</surname> <given-names>T</given-names></name><name><surname>Noji</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators</article-title><source>PNAS</source><volume>106</volume><fpage>15651</fpage><lpage>15656</lpage><pub-id pub-id-type="doi">10.1073/pnas.0904764106</pub-id><pub-id pub-id-type="pmid">19720993</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>K</given-names></name><name><surname>Hotta</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Proliferation pattern of postembryonic neuroblasts in the brain of Drosophila Melanogaster</article-title><source>Developmental Biology</source><volume>149</volume><fpage>134</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(92)90270-Q</pub-id><pub-id pub-id-type="pmid">1728583</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanai</surname> <given-names>MI</given-names></name><name><surname>Okabe</surname> <given-names>M</given-names></name><name><surname>Hiromi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>seven-up Controls switching of transcription factors that specify temporal identities of Drosophila neuroblasts</article-title><source>Developmental cell</source><volume>8</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.12.014</pub-id><pub-id pub-id-type="pmid">15691762</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>K</given-names></name><name><surname>Awasaki</surname> <given-names>T</given-names></name><name><surname>Ito</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neuronal programmed cell death induces glial cell division in the adult Drosophila brain</article-title><source>Development</source><volume>136</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1242/dev.023366</pub-id><pub-id pub-id-type="pmid">19019992</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobloch</surname> <given-names>M</given-names></name><name><surname>Jessberger</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolism and neurogenesis</article-title><source>Current Opinion in Neurobiology</source><volume>42</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2016.11.006</pub-id><pub-id pub-id-type="pmid">27915086</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacin</surname> <given-names>H</given-names></name><name><surname>Truman</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lineage mapping identifies molecular and architectural similarities between the larval and adult Drosophila central nervous system</article-title><source>eLife</source><volume>5</volume><elocation-id>e13399</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13399</pub-id><pub-id pub-id-type="pmid">26975248</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname> <given-names>X</given-names></name><name><surname>Jörg</surname> <given-names>DJ</given-names></name><name><surname>Cavalli</surname> <given-names>FMG</given-names></name><name><surname>Richards</surname> <given-names>LM</given-names></name><name><surname>Nguyen</surname> <given-names>LV</given-names></name><name><surname>Vanner</surname> <given-names>RJ</given-names></name><name><surname>Guilhamon</surname> <given-names>P</given-names></name><name><surname>Lee</surname> <given-names>L</given-names></name><name><surname>Kushida</surname> <given-names>MM</given-names></name><name><surname>Pellacani</surname> <given-names>D</given-names></name><name><surname>Park</surname> <given-names>NI</given-names></name><name><surname>Coutinho</surname> <given-names>FJ</given-names></name><name><surname>Whetstone</surname> <given-names>H</given-names></name><name><surname>Selvadurai</surname> <given-names>HJ</given-names></name><name><surname>Che</surname> <given-names>C</given-names></name><name><surname>Luu</surname> <given-names>B</given-names></name><name><surname>Carles</surname> <given-names>A</given-names></name><name><surname>Moksa</surname> <given-names>M</given-names></name><name><surname>Rastegar</surname> <given-names>N</given-names></name><name><surname>Head</surname> <given-names>R</given-names></name><name><surname>Dolma</surname> <given-names>S</given-names></name><name><surname>Prinos</surname> <given-names>P</given-names></name><name><surname>Cusimano</surname> <given-names>MD</given-names></name><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Bernstein</surname> <given-names>M</given-names></name><name><surname>Arrowsmith</surname> <given-names>CH</given-names></name><name><surname>Mungall</surname> <given-names>AJ</given-names></name><name><surname>Moore</surname> <given-names>RA</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Gallo</surname> <given-names>M</given-names></name><name><surname>Lupien</surname> <given-names>M</given-names></name><name><surname>Pugh</surname> <given-names>TJ</given-names></name><name><surname>Taylor</surname> <given-names>MD</given-names></name><name><surname>Hirst</surname> <given-names>M</given-names></name><name><surname>Eaves</surname> <given-names>CJ</given-names></name><name><surname>Simons</surname> <given-names>BD</given-names></name><name><surname>Dirks</surname> <given-names>PB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy</article-title><source>Nature</source><volume>549</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1038/nature23666</pub-id><pub-id pub-id-type="pmid">28854171</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname> <given-names>ME</given-names></name><name><surname>Sauer</surname> <given-names>K</given-names></name><name><surname>Wallace</surname> <given-names>K</given-names></name><name><surname>Jan</surname> <given-names>YN</given-names></name><name><surname>Lehner</surname> <given-names>CF</given-names></name><name><surname>Vaessin</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during <italic>Drosophila</italic> development</article-title><source>Cell</source><volume>87</volume><fpage>1225</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81818-8</pub-id><pub-id pub-id-type="pmid">8980229</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname> <given-names>C</given-names></name><name><surname>Turrero Garcia</surname> <given-names>M</given-names></name><name><surname>Decimo</surname> <given-names>I</given-names></name><name><surname>Bifari</surname> <given-names>F</given-names></name><name><surname>Eelen</surname> <given-names>G</given-names></name><name><surname>Quaegebeur</surname> <given-names>A</given-names></name><name><surname>Boon</surname> <given-names>R</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Boeckx</surname> <given-names>B</given-names></name><name><surname>Chang</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Le Noble</surname> <given-names>F</given-names></name><name><surname>Lambrechts</surname> <given-names>D</given-names></name><name><surname>Dewerchin</surname> <given-names>M</given-names></name><name><surname>Kuo</surname> <given-names>CJ</given-names></name><name><surname>Huttner</surname> <given-names>WB</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis</article-title><source>The EMBO Journal</source><volume>35</volume><fpage>924</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.15252/embj.201592372</pub-id><pub-id pub-id-type="pmid">26856890</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>CY</given-names></name><name><surname>Robinson</surname> <given-names>KJ</given-names></name><name><surname>Doe</surname> <given-names>CQ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Lgl, Pins and aPKC regulate neuroblast self-renewal versus differentiation</article-title><source>Nature</source><volume>439</volume><fpage>594</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1038/nature04299</pub-id><pub-id pub-id-type="pmid">16357871</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Lee</surname> <given-names>JE</given-names></name><name><surname>Kahng</surname> <given-names>JY</given-names></name><name><surname>Kim</surname> <given-names>SH</given-names></name><name><surname>Park</surname> <given-names>JS</given-names></name><name><surname>Yoon</surname> <given-names>SJ</given-names></name><name><surname>Um</surname> <given-names>JY</given-names></name><name><surname>Kim</surname> <given-names>WK</given-names></name><name><surname>Lee</surname> <given-names>JK</given-names></name><name><surname>Park</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>EH</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Chung</surname> <given-names>WS</given-names></name><name><surname>Ju</surname> <given-names>YS</given-names></name><name><surname>Park</surname> <given-names>SH</given-names></name><name><surname>Chang</surname> <given-names>JH</given-names></name><name><surname>Kang</surname> <given-names>SG</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Human glioblastoma arises from subventricular zone cells with low-level driver mutations</article-title><source>Nature</source><volume>560</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0389-3</pub-id><pub-id pub-id-type="pmid">30069053</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Yang</surname> <given-names>CP</given-names></name><name><surname>Sugino</surname> <given-names>K</given-names></name><name><surname>Fu</surname> <given-names>CC</given-names></name><name><surname>Liu</surname> <given-names>LY</given-names></name><name><surname>Yao</surname> <given-names>X</given-names></name><name><surname>Lee</surname> <given-names>LP</given-names></name><name><surname>Lee</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Opposing intrinsic temporal gradients guide neural stem cell production of varied neuronal fates</article-title><source>Science</source><volume>350</volume><fpage>317</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1126/science.aad1886</pub-id><pub-id pub-id-type="pmid">26472907</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>C</given-names></name><name><surname>Thompson</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Metabolic regulation of epigenetics</article-title><source>Cell Metabolism</source><volume>16</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.06.001</pub-id><pub-id pub-id-type="pmid">22768835</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname> <given-names>S</given-names></name><name><surname>Guptan</surname> <given-names>P</given-names></name><name><surname>Owusu-Ansah</surname> <given-names>E</given-names></name><name><surname>Banerjee</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila</article-title><source>Developmental cell</source><volume>9</volume><fpage>843</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.11.006</pub-id><pub-id pub-id-type="pmid">16326395</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname> <given-names>S</given-names></name><name><surname>Freije</surname> <given-names>WA</given-names></name><name><surname>Guptan</surname> <given-names>P</given-names></name><name><surname>Banerjee</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Metabolic control of G1-S transition: cyclin E degradation by p53-induced activation of the ubiquitin-proteasome system</article-title><source>The Journal of cell biology</source><volume>188</volume><fpage>473</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1083/jcb.200912024</pub-id><pub-id pub-id-type="pmid">20176921</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurange</surname> <given-names>C</given-names></name><name><surname>Cheng</surname> <given-names>L</given-names></name><name><surname>Gould</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Temporal transcription factors and their targets schedule the end of neural proliferation in Drosophila</article-title><source>Cell</source><volume>133</volume><fpage>891</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.03.034</pub-id><pub-id pub-id-type="pmid">18510932</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayers</surname> <given-names>JR</given-names></name><name><surname>Torrence</surname> <given-names>ME</given-names></name><name><surname>Danai</surname> <given-names>LV</given-names></name><name><surname>Papagiannakopoulos</surname> <given-names>T</given-names></name><name><surname>Davidson</surname> <given-names>SM</given-names></name><name><surname>Bauer</surname> <given-names>MR</given-names></name><name><surname>Lau</surname> <given-names>AN</given-names></name><name><surname>Ji</surname> <given-names>BW</given-names></name><name><surname>Dixit</surname> <given-names>PD</given-names></name><name><surname>Hosios</surname> <given-names>AM</given-names></name><name><surname>Muir</surname> <given-names>A</given-names></name><name><surname>Chin</surname> <given-names>CR</given-names></name><name><surname>Freinkman</surname> <given-names>E</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name><name><surname>Wolpin</surname> <given-names>BM</given-names></name><name><surname>Vitkup</surname> <given-names>D</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers</article-title><source>Science</source><volume>353</volume><fpage>1161</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1126/science.aaf5171</pub-id><pub-id pub-id-type="pmid">27609895</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDermott</surname> <given-names>SM</given-names></name><name><surname>Meignin</surname> <given-names>C</given-names></name><name><surname>Rappsilber</surname> <given-names>J</given-names></name><name><surname>Davis</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Drosophila Syncrip binds the gurken mRNA localisation signal and regulates localised transcripts during axis specification</article-title><source>Biology open</source><volume>1</volume><fpage>488</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1242/bio.2012885</pub-id><pub-id pub-id-type="pmid">23213441</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname> <given-names>K</given-names></name><name><surname>Wunder</surname> <given-names>C</given-names></name><name><surname>Roysam</surname> <given-names>B</given-names></name><name><surname>Lin</surname> <given-names>G</given-names></name><name><surname>Lippincott-Schwartz</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase</article-title><source>PNAS</source><volume>106</volume><fpage>11960</fpage><lpage>11965</lpage><pub-id pub-id-type="doi">10.1073/pnas.0904875106</pub-id><pub-id pub-id-type="pmid">19617534</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyares</surname> <given-names>RL</given-names></name><name><surname>Lee</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Temporal control of Drosophila central nervous system development</article-title><source>Current opinion in neurobiology</source><volume>56</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.10.016</pub-id><pub-id pub-id-type="pmid">30500514</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname> <given-names>JR</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Protopopova</surname> <given-names>M</given-names></name><name><surname>Gera</surname> <given-names>S</given-names></name><name><surname>Bandi</surname> <given-names>M</given-names></name><name><surname>Bristow</surname> <given-names>C</given-names></name><name><surname>McAfoos</surname> <given-names>T</given-names></name><name><surname>Morlacchi</surname> <given-names>P</given-names></name><name><surname>Ackroyd</surname> <given-names>J</given-names></name><name><surname>Agip</surname> <given-names>AA</given-names></name><name><surname>Al-Atrash</surname> <given-names>G</given-names></name><name><surname>Asara</surname> <given-names>J</given-names></name><name><surname>Bardenhagen</surname> <given-names>J</given-names></name><name><surname>Carrillo</surname> <given-names>CC</given-names></name><name><surname>Carroll</surname> <given-names>C</given-names></name><name><surname>Chang</surname> <given-names>E</given-names></name><name><surname>Ciurea</surname> <given-names>S</given-names></name><name><surname>Cross</surname> <given-names>JB</given-names></name><name><surname>Czako</surname> <given-names>B</given-names></name><name><surname>Deem</surname> <given-names>A</given-names></name><name><surname>Daver</surname> <given-names>N</given-names></name><name><surname>de Groot</surname> <given-names>JF</given-names></name><name><surname>Dong</surname> <given-names>JW</given-names></name><name><surname>Feng</surname> <given-names>N</given-names></name><name><surname>Gao</surname> <given-names>G</given-names></name><name><surname>Gay</surname> <given-names>J</given-names></name><name><surname>Do</surname> <given-names>MG</given-names></name><name><surname>Greer</surname> <given-names>J</given-names></name><name><surname>Giuliani</surname> <given-names>V</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name><name><surname>Han</surname> <given-names>L</given-names></name><name><surname>Henry</surname> <given-names>VK</given-names></name><name><surname>Hirst</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Kang</surname> <given-names>Z</given-names></name><name><surname>Khor</surname> <given-names>T</given-names></name><name><surname>Konoplev</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>YH</given-names></name><name><surname>Liu</surname> <given-names>G</given-names></name><name><surname>Lodi</surname> <given-names>A</given-names></name><name><surname>Lofton</surname> <given-names>T</given-names></name><name><surname>Ma</surname> <given-names>H</given-names></name><name><surname>Mahendra</surname> <given-names>M</given-names></name><name><surname>Matre</surname> <given-names>P</given-names></name><name><surname>Mullinax</surname> <given-names>R</given-names></name><name><surname>Peoples</surname> <given-names>M</given-names></name><name><surname>Petrocchi</surname> <given-names>A</given-names></name><name><surname>Rodriguez-Canale</surname> <given-names>J</given-names></name><name><surname>Serreli</surname> <given-names>R</given-names></name><name><surname>Shi</surname> <given-names>T</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Tabe</surname> <given-names>Y</given-names></name><name><surname>Theroff</surname> <given-names>J</given-names></name><name><surname>Tiziani</surname> <given-names>S</given-names></name><name><surname>Xu</surname> <given-names>Q</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Muller</surname> <given-names>F</given-names></name><name><surname>DePinho</surname> <given-names>RA</given-names></name><name><surname>Toniatti</surname> <given-names>C</given-names></name><name><surname>Draetta</surname> <given-names>GF</given-names></name><name><surname>Heffernan</surname> <given-names>TP</given-names></name><name><surname>Konopleva</surname> <given-names>M</given-names></name><name><surname>Jones</surname> <given-names>P</given-names></name><name><surname>Di Francesco</surname> <given-names>ME</given-names></name><name><surname>Marszalek</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An inhibitor of oxidative phosphorylation exploits cancer vulnerability</article-title><source>Nature medicine</source><volume>24</volume><fpage>1036</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0052-4</pub-id><pub-id pub-id-type="pmid">29892070</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname> <given-names>TP</given-names></name><name><surname>Kwon</surname> <given-names>S</given-names></name><name><surname>Schnapp</surname> <given-names>BJ</given-names></name><name><surname>St Johnston</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A repeated IMP-binding motif controls oskar mRNA translation and anchoring independently of Drosophila melanogaster IMP</article-title><source>The Journal of cell biology</source><volume>172</volume><fpage>577</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1083/jcb.200510044</pub-id><pub-id pub-id-type="pmid">16476777</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narbonne-Reveau</surname> <given-names>K</given-names></name><name><surname>Lanet</surname> <given-names>E</given-names></name><name><surname>Dillard</surname> <given-names>C</given-names></name><name><surname>Foppolo</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Parrinello</surname> <given-names>H</given-names></name><name><surname>Rialle</surname> <given-names>S</given-names></name><name><surname>Sokol</surname> <given-names>NS</given-names></name><name><surname>Maurange</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neural stem cell-encoded temporal patterning delineates an early window of malignant susceptibility in Drosophila</article-title><source>eLife</source><volume>5</volume><elocation-id>e13463</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13463</pub-id><pub-id pub-id-type="pmid">27296804</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuki</surname> <given-names>L</given-names></name><name><surname>Brand</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell cycle heterogeneity directs the timing of neural stem cell activation from quiescence</article-title><source>Science</source><volume>360</volume><fpage>99</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1126/science.aan8795</pub-id><pub-id pub-id-type="pmid">29622651</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owusu-Ansah</surname> <given-names>E</given-names></name><name><surname>Yavari</surname> <given-names>A</given-names></name><name><surname>Mandal</surname> <given-names>S</given-names></name><name><surname>Banerjee</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint</article-title><source>Nature Genetics</source><volume>40</volume><fpage>356</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/ng.2007.50</pub-id><pub-id pub-id-type="pmid">18246068</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owusu-Ansah</surname> <given-names>E</given-names></name><name><surname>Song</surname> <given-names>W</given-names></name><name><surname>Perrimon</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Muscle mitohormesis promotes longevity via systemic repression of insulin signaling</article-title><source>Cell</source><volume>155</volume><fpage>699</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.09.021</pub-id><pub-id pub-id-type="pmid">24243023</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pletcher</surname> <given-names>RC</given-names></name><name><surname>Hardman</surname> <given-names>SL</given-names></name><name><surname>Intagliata</surname> <given-names>SF</given-names></name><name><surname>Lawson</surname> <given-names>RL</given-names></name><name><surname>Page</surname> <given-names>A</given-names></name><name><surname>Tennessen</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A genetic screen using the <italic>Drosophila melanogaster</italic> TRiP RNAi Collection To Identify Metabolic Enzymes Required for Eye Development</article-title><source>G3: Genes, Genomes, Genetics</source><volume>9</volume><fpage>2061</fpage><lpage>2070</lpage><pub-id pub-id-type="doi">10.1534/g3.119.400193</pub-id><pub-id pub-id-type="pmid">31036678</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname> <given-names>DM</given-names></name><name><surname>Jin</surname> <given-names>Z</given-names></name><name><surname>Rabinovitch</surname> <given-names>S</given-names></name><name><surname>Campbell</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Ectopic expression of the Drosophila Cdk1 inhibitory kinases, Wee1 and Myt1, interferes with the second mitotic wave and disrupts pattern formation during eye development</article-title><source>Genetics</source><volume>161</volume><fpage>721</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">12072468</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzuto</surname> <given-names>R</given-names></name><name><surname>Brini</surname> <given-names>M</given-names></name><name><surname>Pizzo</surname> <given-names>P</given-names></name><name><surname>Murgia</surname> <given-names>M</given-names></name><name><surname>Pozzan</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells</article-title><source>Current Biology</source><volume>5</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(95)00128-X</pub-id><pub-id pub-id-type="pmid">7552174</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schieke</surname> <given-names>SM</given-names></name><name><surname>McCoy</surname> <given-names>JP</given-names></name><name><surname>Finkel</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Coordination of mitochondrial bioenergetics with G1 phase cell cycle progression</article-title><source>Cell Cycle</source><volume>7</volume><fpage>1782</fpage><lpage>1787</lpage><pub-id pub-id-type="doi">10.4161/cc.7.12.6067</pub-id><pub-id pub-id-type="pmid">18583942</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Lim</surname> <given-names>SK</given-names></name><name><surname>Liang</surname> <given-names>Q</given-names></name><name><surname>Iyer</surname> <given-names>SV</given-names></name><name><surname>Wang</surname> <given-names>H-Y</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name><name><surname>Sun</surname> <given-names>D</given-names></name><name><surname>Chen</surname> <given-names>Y-J</given-names></name><name><surname>Tabar</surname> <given-names>V</given-names></name><name><surname>Gutin</surname> <given-names>P</given-names></name><name><surname>Williams</surname> <given-names>N</given-names></name><name><surname>De Brabander</surname> <given-names>JK</given-names></name><name><surname>Parada</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma</article-title><source>Nature</source><volume>567</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0993-x</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegrist</surname> <given-names>SE</given-names></name><name><surname>Haque</surname> <given-names>NS</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Hay</surname> <given-names>BA</given-names></name><name><surname>Hariharan</surname> <given-names>IK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inactivation of both foxo and reaper promotes long-term adult neurogenesis in Drosophila</article-title><source>Current Biology</source><volume>20</volume><fpage>643</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2010.01.060</pub-id><pub-id pub-id-type="pmid">20346676</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotillos</surname> <given-names>S</given-names></name><name><surname>Díaz-Meco</surname> <given-names>MT</given-names></name><name><surname>Caminero</surname> <given-names>E</given-names></name><name><surname>Moscat</surname> <given-names>J</given-names></name><name><surname>Campuzano</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>DaPKC-dependent phosphorylation of crumbs is required for epithelial cell polarity in Drosophila</article-title><source>The Journal of Cell Biology</source><volume>166</volume><fpage>549</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1083/jcb.200311031</pub-id><pub-id pub-id-type="pmid">15302858</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>LB</given-names></name><name><surname>Gui</surname> <given-names>DY</given-names></name><name><surname>Hosios</surname> <given-names>AM</given-names></name><name><surname>Bush</surname> <given-names>LN</given-names></name><name><surname>Freinkman</surname> <given-names>E</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells</article-title><source>Cell</source><volume>162</volume><fpage>552</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.017</pub-id><pub-id pub-id-type="pmid">26232225</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>LB</given-names></name><name><surname>Luengo</surname> <given-names>A</given-names></name><name><surname>Danai</surname> <given-names>LV</given-names></name><name><surname>Bush</surname> <given-names>LN</given-names></name><name><surname>Diehl</surname> <given-names>FF</given-names></name><name><surname>Hosios</surname> <given-names>AM</given-names></name><name><surname>Lau</surname> <given-names>AN</given-names></name><name><surname>Elmiligy</surname> <given-names>S</given-names></name><name><surname>Malstrom</surname> <given-names>S</given-names></name><name><surname>Lewis</surname> <given-names>CA</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Aspartate is an endogenous metabolic limitation for tumour growth</article-title><source>Nature Cell Biology</source><volume>20</volume><fpage>782</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0125-0</pub-id><pub-id pub-id-type="pmid">29941931</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taverna</surname> <given-names>E</given-names></name><name><surname>Götz</surname> <given-names>M</given-names></name><name><surname>Huttner</surname> <given-names>WB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The cell biology of neurogenesis: toward an understanding of the development and evolution of the neocortex</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>30</volume><fpage>465</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-101011-155801</pub-id><pub-id pub-id-type="pmid">25000993</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Technau</surname> <given-names>GM</given-names></name><name><surname>Berger</surname> <given-names>C</given-names></name><name><surname>Urbach</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Generation of cell diversity and segmental pattern in the embryonic central nervous system of Drosophila</article-title><source>Developmental Dynamics</source><volume>235</volume><fpage>861</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20566</pub-id><pub-id pub-id-type="pmid">16222713</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname> <given-names>FK</given-names></name><name><surname>Sanchez</surname> <given-names>CG</given-names></name><name><surname>Hurd</surname> <given-names>TR</given-names></name><name><surname>Seifert</surname> <given-names>JR</given-names></name><name><surname>Czech</surname> <given-names>B</given-names></name><name><surname>Preall</surname> <given-names>JB</given-names></name><name><surname>Hannon</surname> <given-names>GJ</given-names></name><name><surname>Lehmann</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ATP synthase promotes germ cell differentiation independent of oxidative phosphorylation</article-title><source>Nature Cell Biology</source><volume>17</volume><fpage>689</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1038/ncb3165</pub-id><pub-id pub-id-type="pmid">25915123</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tennessen</surname> <given-names>JM</given-names></name><name><surname>Baker</surname> <given-names>KD</given-names></name><name><surname>Lam</surname> <given-names>G</given-names></name><name><surname>Evans</surname> <given-names>J</given-names></name><name><surname>Thummel</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth</article-title><source>Cell Metabolism</source><volume>13</volume><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.01.005</pub-id><pub-id pub-id-type="pmid">21284981</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tennessen</surname> <given-names>JM</given-names></name><name><surname>Bertagnolli</surname> <given-names>NM</given-names></name><name><surname>Evans</surname> <given-names>J</given-names></name><name><surname>Sieber</surname> <given-names>MH</given-names></name><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Thummel</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Coordinated metabolic transitions during Drosophila embryogenesis and the onset of aerobic glycolysis</article-title><source>G3: Genes, Genomes, Genetics</source><volume>4</volume><fpage>839</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1534/g3.114.010652</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiberi</surname> <given-names>L</given-names></name><name><surname>Vanderhaeghen</surname> <given-names>P</given-names></name><name><surname>van den Ameele</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cortical neurogenesis and morphogens: diversity of cues, sources and functions</article-title><source>Current Opinion in Cell Biology</source><volume>24</volume><fpage>269</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2012.01.010</pub-id><pub-id pub-id-type="pmid">22342580</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiberi</surname> <given-names>L</given-names></name><name><surname>Bonnefont</surname> <given-names>J</given-names></name><name><surname>van den Ameele</surname> <given-names>J</given-names></name><name><surname>Le Bon</surname> <given-names>SD</given-names></name><name><surname>Herpoel</surname> <given-names>A</given-names></name><name><surname>Bilheu</surname> <given-names>A</given-names></name><name><surname>Baron</surname> <given-names>BW</given-names></name><name><surname>Vanderhaeghen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A BCL6/BCOR/SIRT1 complex triggers neurogenesis and suppresses medulloblastoma by repressing sonic hedgehog signaling</article-title><source>Cancer Cell</source><volume>26</volume><fpage>797</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2014.10.021</pub-id><pub-id pub-id-type="pmid">25490446</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Titov</surname> <given-names>DV</given-names></name><name><surname>Cracan</surname> <given-names>V</given-names></name><name><surname>Goodman</surname> <given-names>RP</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Grabarek</surname> <given-names>Z</given-names></name><name><surname>Mootha</surname> <given-names>VK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio</article-title><source>Science</source><volume>352</volume><fpage>231</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1126/science.aad4017</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trovisco</surname> <given-names>V</given-names></name><name><surname>Belaya</surname> <given-names>K</given-names></name><name><surname>Nashchekin</surname> <given-names>D</given-names></name><name><surname>Irion</surname> <given-names>U</given-names></name><name><surname>Sirinakis</surname> <given-names>G</given-names></name><name><surname>Butler</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>JJ</given-names></name><name><surname>Gavis</surname> <given-names>ER</given-names></name><name><surname>St Johnston</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Bicoid</italic> mRNA localises to the <italic>Drosophila</italic> oocyte anterior by random Dynein-mediated transport and anchoring</article-title><source>eLife</source><volume>5</volume><elocation-id>e17537</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17537</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truman</surname> <given-names>JW</given-names></name><name><surname>Bate</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Spatial and temporal patterns of neurogenesis in the central nervous system of Drosophila Melanogaster</article-title><source>Developmental Biology</source><volume>125</volume><fpage>145</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(88)90067-X</pub-id><pub-id pub-id-type="pmid">3119399</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuyama</surname> <given-names>T</given-names></name><name><surname>Kishikawa</surname> <given-names>J-ichi</given-names></name><name><surname>Han</surname> <given-names>Y-W</given-names></name><name><surname>Harada</surname> <given-names>Y</given-names></name><name><surname>Tsubouchi</surname> <given-names>A</given-names></name><name><surname>Noji</surname> <given-names>H</given-names></name><name><surname>Kakizuka</surname> <given-names>A</given-names></name><name><surname>Yokoyama</surname> <given-names>K</given-names></name><name><surname>Uemura</surname> <given-names>T</given-names></name><name><surname>Imamura</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In Vivo Fluorescent Adenosine 5′-Triphosphate (ATP) Imaging of <italic>Drosophila melanogaster</italic> and <italic>Caenorhabditis elegans</italic> by Using a Genetically Encoded Fluorescent ATP Biosensor Optimized for Low Temperatures</article-title><source>Analytical Chemistry</source><volume>85</volume><fpage>7889</fpage><lpage>7896</lpage><pub-id pub-id-type="doi">10.1021/ac4015325</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name><name><surname>Cantley</surname> <given-names>LC</given-names></name><name><surname>Thompson</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Understanding the warburg effect: the metabolic requirements of cell proliferation</article-title><source>Science</source><volume>324</volume><fpage>1029</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1126/science.1160809</pub-id><pub-id pub-id-type="pmid">19460998</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name><name><surname>DeBerardinis</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Understanding the intersections between metabolism and Cancer biology</article-title><source>Cell</source><volume>168</volume><fpage>657</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.12.039</pub-id><pub-id pub-id-type="pmid">28187287</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villegas</surname> <given-names>SN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>One hundred years of <italic>Drosophila</italic> Cancer research: no longer in solitude</article-title><source>Disease Models &amp; Mechanisms</source><volume>12</volume><elocation-id>dmm039032</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.039032</pub-id><pub-id pub-id-type="pmid">30952627</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Trotha</surname> <given-names>JW</given-names></name><name><surname>Egger</surname> <given-names>B</given-names></name><name><surname>Brand</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cell proliferation in the Drosophila adult brain revealed by clonal analysis and bromodeoxyuridine labelling</article-title><source>Neural Development</source><volume>4</volume><elocation-id>9</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-4-9</pub-id><pub-id pub-id-type="pmid">19254370</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>CW</given-names></name><name><surname>Purkayastha</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>KT</given-names></name><name><surname>Thaker</surname> <given-names>SK</given-names></name><name><surname>Banerjee</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo genetic dissection of tumor growth and the warburg effect</article-title><source>eLife</source><volume>5</volume><elocation-id>e18126</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.18126</pub-id><pub-id pub-id-type="pmid">27585295</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="1956">1956</year><article-title>On the origin of Cancer cells</article-title><source>Science</source><volume>123</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1126/science.123.3191.309</pub-id><pub-id pub-id-type="pmid">13298683</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberg</surname> <given-names>SE</given-names></name><name><surname>Chandel</surname> <given-names>NS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Targeting mitochondria metabolism for Cancer therapy</article-title><source>Nature Chemical Biology</source><volume>11</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1712</pub-id><pub-id pub-id-type="pmid">25517383</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>KKL</given-names></name><name><surname>Liao</surname> <given-names>JZ</given-names></name><name><surname>Verheyen</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A positive feedback loop between myc and aerobic glycolysis sustains tumor growth in a <italic>Drosophila</italic> tumor model</article-title><source>eLife</source><volume>8</volume><elocation-id>e46315</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.46315</pub-id><pub-id pub-id-type="pmid">31259690</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>YC</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Mercer</surname> <given-names>A</given-names></name><name><surname>Sokol</surname> <given-names>NS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Let-7-complex microRNAs regulate the temporal identity of Drosophila mushroom body neurons via chinmo</article-title><source>Developmental Cell</source><volume>23</volume><fpage>202</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.05.013</pub-id><pub-id pub-id-type="pmid">22814608</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>CP</given-names></name><name><surname>Samuels</surname> <given-names>TJ</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Ish-Horowicz</surname> <given-names>D</given-names></name><name><surname>Davis</surname> <given-names>I</given-names></name><name><surname>Lee</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Imp and syp RNA-binding proteins govern decommissioning of <italic>Drosophila</italic> neural stem cells</article-title><source>Development</source><volume>144</volume><fpage>3454</fpage><lpage>3464</lpage><pub-id pub-id-type="doi">10.1242/dev.149500</pub-id><pub-id pub-id-type="pmid">28851709</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Boyer</surname> <given-names>L</given-names></name><name><surname>Jin</surname> <given-names>M</given-names></name><name><surname>Mertens</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Hamm</surname> <given-names>M</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>Hunter</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation</article-title><source>eLife</source><volume>5</volume><elocation-id>e13374</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13374</pub-id><pub-id pub-id-type="pmid">27282387</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zielke</surname> <given-names>N</given-names></name><name><surname>Korzelius</surname> <given-names>J</given-names></name><name><surname>van Straaten</surname> <given-names>M</given-names></name><name><surname>Bender</surname> <given-names>K</given-names></name><name><surname>Schuhknecht</surname> <given-names>GFP</given-names></name><name><surname>Dutta</surname> <given-names>D</given-names></name><name><surname>Xiang</surname> <given-names>J</given-names></name><name><surname>Edgar</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fly-FUCCI: a versatile tool for studying cell proliferation in complex tissues</article-title><source>Cell Reports</source><volume>7</volume><fpage>588</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.020</pub-id><pub-id pub-id-type="pmid">24726363</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.47887.021</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role>Reviewing Editor</role><aff><institution>New York University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;OxPhos-dependent stem cell proliferation drives temporal patterning and tumour growth in the developing brain&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by four peer reviewers, and the evaluation has been overseen by Claude Desplan as Reviewing Editor and Utpal Banerjee as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. The four reviewers agree on the significance and importance of the paper and the quality of the data presented, especially since the Warburg effect is the topic of so much discussion. It was thought that normal NSC and brat tumors do well without OxPhos while the manuscript proves that this might not be the case. The paper clearly makes this point, which is important.</p><p>However, there are several serious criticisms that need to be addressed before the paper can be considered.</p><p>- A better presentation of the problem.</p><p>- One major concern is that the paper does not really examine glycolysis; it demonstrates that knocking down two essential components of OxPhos compromises normal NSC development as well as larval brain tumor growth. Refocusing the text on OxPhos while discussing the results in the context of Homem et al. and Mandal et al. would significantly improve the manuscript. It should be noted that the manuscript neither confirms nor discards the previously claimed Glycolysis-to-OxPhos transition.</p><p>- The lack of metabolic characterization of mutants. A revised version should examine mitochondria morphology, their membrane potential, and ATP levels.</p><p>- One reviewer would also like the paper to address the possibility that these are glial effects.</p><p>- Delete the over-interpretations. In particular, the title must be changed to reflect this: &quot;drive&quot; is an overstatement as the manuscript shows it to be &quot;necessary&quot;.</p><p>The reviews below are quite detailed and should help you improve the manuscript for publication.</p><p><italic>Reviewer #1:</italic></p><p>This manuscript by van den Ameele and Brand addresses the interesting question of metabolic reprogramming during tumor formation or stem cell behavior. Authors use <italic>Drosophila</italic> neural stem cells as a model and show that reducing OxPhos by the knock down of specific components of the respiratory chain complexes, either during uncontrolled NSC proliferation or during normal NSC life, alters their proliferation, blocks the cells in G<sub>1</sub>/S and affects the terminal differentiation of NSCs. This finding may be of interest in the context of many studies showing that tumor cells as well as stem cells require OxPhos for their proliferative activity.</p><p>However, the conclusions of the experiments are in some instances overstated. The general context of the study, presented as a re-evaluation of the Warburg hypothesis for NSC-derived tumors, is also somehow misleading for two reasons:</p><p>1) Most of the experiments presented are made in the context of normal NSC development.</p><p>2) One cannot exclude a more trivial interpretation of the data, whereby OxPhos inhibition triggers a general cellular stress response leading to G<sub>1</sub>/S arrest. In which case, the study fails addressing the role of OxPhos versus glycolytic pathways in the maintenance of stem cell identity or tumor formation, as stated in the title, Abstract and Discussion.</p><p>The authors may want to consider rewiring their manuscript and highlight the major strength of the paper, i.e. the demonstration that a proper sequence of cell cycle progression in the NSCs is required for their differentiation program to be completed.</p><p>1) The title is misleading. The authors do not address whether OxPhos is sufficient for NSC or tumor proliferation. Therefore, &quot;drive&quot; seems inappropriate. The Abstract is also misleading (see above).</p><p>2) Figure 1 lacks an important piece of information: what driver is used for the knockdown? Figure 1I lacks controls RNAi + Complex1 RNAi, which is on the next figure. Inhibition of glycolysis should be presented as a negative control.</p><p>3) A control for apoptosis should be presented in the case of tumors.</p><p>4) Figure 3: why only 10% NSCs fail to differentiate into Syp-positive, when up to 50% fail to reduce Imp expression upon CI knock-down?</p><p>5) Title of the last Results paragraph (&quot;OxPhos dysfunction…) is confusing, as the data is: why do CI or CV silenced-NSCs continue to proliferate in adults if they arrest in G<sub>1</sub>/S during larva? How can one know that the same cells that arrest in G1 in larva are the one that proliferate in adult? More explanation/data is needed to establish this result.</p><p><italic>Reviewer #2:</italic></p><p>In 2014, Homem et al., reported that in the transition from larval to pupal stages, oxygen consumption rate (OCR) increases and lactate level goes down, and documented a concomitant increase in the expression of genes encoding several enzymes that control rate-limiting steps of related metabolic pathways including the Krebs cycle. They concluded that terminal differentiation of <italic>Drosophila</italic> NSCs is brought about by induction of respiratory chain and oxidative phosphorylation (OxPhos). Moreover, because brat mutant NSCs do not terminally differentiate, Homem and colleagues hypothesised that loss of brat must render NSCs unable to respond to this developmental program.</p><p>In the submitted manuscript, van den Ameele and Brand set out to re-asses such a Warburg-like effect both in NSCs and in larval brain tumours. They show that NSCs require OxPhos activity not only for timely termination of cell proliferation, but also, critically, through NSC development to control cell cycle progression, which is essential to control temporal patterning and to ensure neuronal diversity. They also show that OxPhos activity is required to maintain a normal rate of cell proliferation and cell heterogeneity in different types of larval brain tumours. From these data they conclude that both wild-type and tumoral NSCs require OxPhos for proliferation and to generate cellular diversity.</p><p>These results challenge those from the previous article on two accounts. Firstly, they very strongly suggest that the key to timely termination of NSC proliferation is not a switch from glycolysis to OxPhos at the onset of pupal life, but substained OxPhos activity throughout NSC development. Secondly they demonstrate three different larval brain tumour types (pros, aPKC-CAAX, and, brat itself) are in fact tightly dependent upon OxPhos. Thus, in short, aerobic glycolysis is not sufficient for normal NSCs development and sustained tumour growth in the <italic>Drosophila</italic> brain.</p><p>The reported work has been carried out to high standards; experiments are well designed and controlled; and results are thoroughly documented and conveniently discussed.</p><p>These are important results. They are also timely because the Warburg effect it is only too often assumed to be a unescapable trait of human cancer (when in fact it is not) and, by extension of <italic>Drosophila</italic> tumours too.</p><p>The one key standing question that the authors have not addressed is whether or not the reported Glycolysis-to-OxPhos transition takes place. The finding that OxPhos is needed throughout NSC development casts serious doubts on the physiological need for such a switch to mostly respiratory metabolism. Moreover, the proposed switch rests on slim evidence, i.e. a 1.2 fold increase in OCR (and that is comparing entire brains, not NSCs).</p><p>Other points:</p><p>&quot;We assessed whether OxPhos inhibition promotes the differentiation and early depletion of the Imp-positive stem cells. This would result in Imp-negative tumour cells with limited self-renewal capacity (Genovese et al., 2018)&quot;. I do not grasp the rationale behind this experiment.</p><p>The article &quot;in vivo genetic dissection of tumour growth and the Warburg effect&quot; (Wang et al., 2016) should be cited and discussed. It makes a strong claim on the relevance of the Warburg effect in a different type of tumour in flies.</p><p>Figure 1H, At first, I could not appreciate the blue rim on the aPKC-CAAX cell cartoon (it looked all green to me). Using better contrasted colours might help.</p><p><italic>Reviewer #3:</italic></p><p>This manuscript examines the requirement for OXPHOS during development of <italic>Drosophila</italic> neuronal stem cells. Using an RNAi-based approach, the authors demonstrate that disruption of either complex I or complex V slows both normal brain growth and tumor growth. Moreover, this growth phenotype stems from a decreased cell proliferation and defects in temporal patterning.</p><p>Overall, I like the experimental foundation of this paper and I think it will ultimately be quite interesting. While there are experimental shortcomings (see below), the major issue is in regard to the Introduction and Discussion, which fail to place the reader in an appropriate mindset, and as a result, fail to highlight interesting findings. Specifically, the Introduction and Discussion are underdeveloped and devoted a significant number of sentences to providing an overly simplistic discussion of aerobic glycolysis. The text in these sections leads the reader to believe that the paper is devoted to aerobic glycolysis, as evident the final sentence which states that the goal of the study is to examine the role of the Warburg effect in NSCs. Similarly, the first paragraph concludes with a sentence about aerobic glycolysis. But nowhere in the manuscript do the authors examine the role of aerobic glycolysis within NSCs. There are no assays dedicated to studying glycolytic metabolism nor do they disrupt glycolysis in these cells. In fact, they never even measure lactate production – the hallmark byproduct of aerobic glycolysis. I'm not sure why the paper is setup in this manner, other than the possibility that the authors are really annoyed with the inappropriate manner by which other labs sometimes use the term &quot;aerobic glycolysis.&quot;</p><p>This unwarranted focus on aerobic glycolysis produces a manuscript that lacks direction. All experiments are devoted to studying OXPHOS, yet the reader is focused on glycolysis. I recommend that the authors entirely rewrite the Introduction and Discussion with a focus on the importance of OXPHOS in both cancer and normal developmental growth. OXPHOS is clearly essential in both cancer and developmental growth. In fact, the most recent in vivo 13C-glucose labeling experiments in human patients suggest that most tumors are highly dependent on OXPHOS. Here the authors describe a new system for studying the link between OXPHOS and cell proliferation! Describe why these findings regarding OXPHOS are important and forget about aerobic glycolysis – unless the authors really want to devote a significant amount to experimental effort (far beyond the scope of a simple revision) to prove their hypothesis that aerobic glycolysis (as defined by elevated glucose consumption and oxygen-independent lactate production) is not important in this context.</p><p>As a second offshoot of my concern regarding the text, the results herein are clearly related to the studies by Homem et al., 2014, and Mandal et al., 2005, yet, little effort is made to discuss the results in the context of these earlier studies. I don't think that this previous work detracts from the novelty of the study and the lack of discussion is annoying.</p><p>My other major concern is that the results are descriptive and lack some rather basic metabolic characterizations. Specifically, there is no metabolic characterization of the cells expressing the complex I and complex V RNAi constructs. Since the manuscript argues that these RNAi treatments are disrupting the cell cycle as the result of defects in OXPHOS, the resulting metabolic defects should be characterized. At a minimum, the authors should examine mitochondrial morphology and ATP levels. All of these parameters can be measured using previously published reagents.</p><p>Finally, the Results section would be enhanced with a few simple experiments that would make sense in light of previous CoVa (tenured) studies (Mandal et al., 2005), which demonstrate that disruption of Complex IV results in a G<sub>1</sub>/S arrest that is dependent on AMPK and p53. The authors briefly elude to these similarities, but fail to address the model. A few simple genetic experiments, such as determining if RNAi-depletion of AMPK suppresses the OXPHOS-induced defects, would significantly enhance the impact of the study.</p><p><italic>Reviewer #4:</italic></p><p>The role of metabolism in modulating development and cancer progression is a fascinating and active area of research. As the authors argue, many studies have focused on the role of aerobic fermentation and one carbon metabolism in fueling growth, but relatively little attention has been paid to OxPhos. In this study the authors argue that oxphos is necessary for proliferation, temporal patterning and differentiation of NSCs. This is a good study that exploits the tools of <italic>Drosophila melanogaster</italic> to address an important question.</p><p>I am asking the authors to address the points below:</p><p>While the data showing that KD of OxPhos affects different aspects of NSCs are strong, the argument that OxPhos is affected is only genetic. Given the strength of the authors' claim and the fact that changing the mRNA levels of metabolic enzymes often results in compensatory or unforeseen effects, the authors should validate that their manipulations affect OxPhos using different assays. This would make the manuscript much stronger, as there would be direct, rather than genetic (inferential), data about OxPhos.</p><p>OxPhos is dispensable for neuronal function, but required in glia (Volkenhoff, 2015). Since NSC can give rise to glial precursors, and glia in turn can support NSCs proliferation and differentiation, is it possible that the phenotypes observed are due to an absence or change in glia?</p><p>Given that the brain controls growth of the organism, could changes in brain size, especially when the manipulations result in a smaller brain, be because the larvae are smaller? A way to compare brain size to body length or to another independent metric would be beneficial.</p><p>The authors use the word &quot;cause&quot; in the Results and Discussion section; however, their experiments show that OxPhos is necessary for proliferation, not that it is sufficient, thus there is no direct evidence that it &quot;causes or drives&quot; temporal patterning, proliferation, and differentiation.</p><p>There is no GAL4 control in the figures.</p><p>There is no validation of the efficacy of the RNAi transgenes by qPCR.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.47887.022</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>[…] There are several serious criticisms that need to be addressed before the paper can be considered.</p><p>- A better presentation of the problem.</p><p>- One major concern is that the paper does not really examine glycolysis; it demonstrates that knocking down two essential components of OxPhos compromises normal NSC development as well as larval brain tumor growth. Refocusing the text on OxPhos while discussing the results in the context of Homem et al. and Mandal et al. would significantly improve the manuscript. It should be noted that the manuscript neither confirms nor discards the previously claimed Glycolysis-to-OxPhos transition.</p></disp-quote><p>As suggested by the editor and reviewers 1 and 3, the text has now been refocused on the role of OxPhos in NSCs and brain tumours, and we provide more discussion of Homem et al. and Mandal et al.</p><p>- The introduction describes the role of OxPhos in proliferating cells. We introduce normal development of the <italic>Drosophila</italic> CNS and present the <italic>Drosophila</italic> literature on metabolism in tumour cells (Eichenlaub et al., 2018; Wang et al., 2016; Wong et al., 2019). We also introduce the papers from the Banerjee lab (Mandal et al., 2010, 2005; Owusu-Ansah et al., 2008).</p><p>- We performed knockdown of glycolysis enzymes in NSCs and in tumour cells and included these data in Figure 1, Figure 1—figure supplement 1, 2 and Figure 2—figure supplement 1.</p><p>- The Discussion now clearly states that based on our results we cannot confirm nor discard the presence or absence of the metabolic switch described in Homem et al. However, we also explain that our data provide an alternative interpretation of how OxPhos dysfunction affects termination of NSC proliferation.</p><disp-quote content-type="editor-comment"><p>- The lack of metabolic characterization of mutants. A revised version should examine mitochondria morphology, their membrane potential, and ATP levels.</p></disp-quote><p>To further validate the effect of knockdown of complex I (NDUFS1) and complex V (ATPsynα) on mitochondrial metabolism, we performed the following experiments (Figure 1—figure supplement 2):</p><p>- We assessed mitochondrial morphology using STED super-resolution microscopy (conventional confocal microscopy did not resolve individual mitochondria in an intact brain). Both complex I and complex V knockdown showed increased fragmentation of mitochondria in NSCs (Figure 1—figure supplement 2D-F).</p><p>- We measured ATP concentration in vivo using a previously validated ATP sensor (Tsuyama et al., 2013). Baseline ATP levels were not affected, but after complex V knockdown, NSCs showed a stronger drop in ATP levels upon acute pharmacological inhibition of glycolysis (Figure 1—figure supplement 2G-I), suggesting that this knockdown affects mitochondrial metabolism and results in rewiring cellular metabolism to rely more on glycolysis.</p><disp-quote content-type="editor-comment"><p>- One reviewer would also like the paper to address the possibility that these are glial effects.</p></disp-quote><p>We did knock down the same complex I and complex V subunits in glia using Repo-Gal4 and assessed the effects on NSCs. In addition, we temporally restricted complex I knockdown to a period in development when cortex glia have already been generated. The results are described in the response to reviewer 4.</p><disp-quote content-type="editor-comment"><p>- Delete the over-interpretations. In particular, the title must be changed to reflect this: &quot;drive&quot; is an overstatement as the manuscript shows it to be &quot;necessary&quot;.</p></disp-quote><p>The title, Abstract and Discussion have been changed to reflect that OxPhos is necessary rather than sufficient for the phenotype. The new title is: “Neural stem cell temporal patterning and brain tumour growth rely on oxidative phosphorylation”</p><disp-quote content-type="editor-comment"><p>The reviews below are quite detailed and should help you improve the manuscript for publication.</p><p>Reviewer #1:</p><p>[…] The conclusions of the experiments are in some instances overstated. The general context of the study, presented as a re-evaluation of the Warburg hypothesis for NSC-derived tumors, is also somehow misleading for two reasons:</p><p>1) Most of the experiments presented are made in the context of normal NSC development.</p></disp-quote><p>The Introduction has now been refocused:</p><p>- We introduce the importance of OxPhos in proliferating cells.</p><p>- We introduce the papers that investigate metabolism of NSCs, in vertebrates as well as in <italic>Drosophila</italic>.</p><p>- We describe normal development of the <italic>Drosophila</italic> CNS and highlight the <italic>Drosophila</italic> literature on metabolism in tumour cells (Eichenlaub et al., 2018; Wang et al., 2016; Wong et al., 2019).</p><p>- The aim of the paper, as stated at the end of the Introduction now focusses on investigating the role of OxPhos in proliferating NSCs and in tumour cells.</p><disp-quote content-type="editor-comment"><p>2) One cannot exclude a more trivial interpretation of the data, whereby OxPhos inhibition triggers a general cellular stress response leading to G<sub>1</sub>/S arrest. In which case, the study fails addressing the role of OxPhos versus glycolytic pathways in the maintenance of stem cell identity or tumor formation, as stated in the title, Abstract and Discussion.</p></disp-quote><p>We have now performed knockdown of glycolysis enzymes in NSCs and in tumour cells and included these data in Figure 1, Figure 1—figure supplement 1, 2 and Figure 2—figure supplement 1. This shows that NSC-specific knockdown of PFK, aldolase and PGK does not affect brain size, but knockdown of PyK results in smaller brains. We also tested aldolase knockdown in Pros tumours and found that it, in contrast to normal NSCs, their growth is significantly decreased.</p><p>We agree that the phenotypes we observe are probably mediated through activation of cellular stress pathways, which, among others, lead to G<sub>1</sub>/S delay, similar to what was shown in Owusu-Ansah et al., 2008 where complex I dysfunction in the <italic>Drosophila</italic> eye disc leads to ROS production and activation of the stress-response through the JNK-pathway.</p><p>An in-depth analysis of the pathways mediating this response is beyond the scope of our paper but we have now included the following results:</p><p>- Figure 1—figure supplement 2G-I: baseline ATP levels are not decreased upon chronic inhibition of complex V in NSCs. However, ATP levels drop more significantly upon acute inhibition of glycolysis when complex V is inhibited than in the control NSCs. This suggests that part of the response is an increased reliance on glycolysis.</p><p>- Figure 4—figure supplement 2: <italic>Ampk</italic> mutation does not rescue proliferation or temporal patterning, and actually makes it worse. This might suggest that AMPK plays a compensatory role in the response to OxPhos dysfunction.</p><disp-quote content-type="editor-comment"><p>The authors may want to consider rewiring their manuscript and highlight the major strength of the paper, i.e. the demonstration that a proper sequence of cell cycle progression in the NSCs is required for their differentiation program to be completed.</p></disp-quote><p>The text has been refocused on the role of OxPhos in NSCs and brain tumours. The Introduction now also describes normal development of the <italic>Drosophila</italic> CNS, and the role of temporal patterning in generation of neuronal diversity. In the Discussion, we provide more explanation of the differences with Homem et al., and discuss how our findings may impact on the current understanding of NSC diversity and normal temporal patterning of NSCs.</p><disp-quote content-type="editor-comment"><p>1) The title is misleading. The authors do not address whether OxPhos is sufficient for NSC or tumor proliferation. Therefore, &quot;drive&quot; seems inappropriate. The Abstract is also misleading (see above).</p></disp-quote><p>The title, Abstract and Discussion have been changed to reflect that OxPhos is necessary rather than sufficient for the phenotype. The new title is: “Neural stem cell temporal patterning and brain tumour growth rely on oxidative phosphorylation”</p><disp-quote content-type="editor-comment"><p>2) Figure 1 lacks an important piece of information: what driver is used for the knockdown? Figure 1I lacks controls RNAi + Complex1 RNAi, which is on the next figure. Inhibition of glycolysis should be presented as a negative control.</p></disp-quote><p>- The driver used for the knockdown is Worniu-Gal4. This is now mentioned in the text and figure legend.</p><p>- We performed additional experiments and included the data from the control RNAi + Complex I or V RNAi crosses in Figure 1l.</p><p>- We knocked down aldolase in Pros tumours and observed a significant decrease in tumour growth. These data are now included in Figure 1—figure supplement 1A-C.</p><disp-quote content-type="editor-comment"><p>3) A control for apoptosis should be presented in the case of tumors.</p></disp-quote><p>TUNEL staining in the Pros-RNAi brains is now presented in Figure 1—figure supplement 1. We observed no obvious increase in apoptosis upon knockdown of complex I or complex V.</p><disp-quote content-type="editor-comment"><p>4) Figure 3: why only 10% NSCs fail to differentiate into Syp-positive, when up to 50% fail to reduce Imp expression upon CI knock-down?</p></disp-quote><p>The transition from Imp- to Syp-expression is gradual (Liu et al., 2015), and many cells that fail to downregulate Imp upon OxPhos knockdown do express Syp anyway. This is illustrated in <xref ref-type="fig" rid="respfig1">Author response image 1</xref> (NSCs with complex I RNAi), whereby Worniu&gt;GFP-positive NSCs that remain Imp-positive often are Syp-positive as well (double-positive NSCs are indicated by arrowheads).</p><fig id="respfig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-resp-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>5) Title of the last Results paragraph (&quot;OxPhos dysfunction…) is confusing, as the data is: why do CI or CV silenced-NSCs continue to proliferate in adults if they arrest in G<sub>1</sub>/S during larva? How can one know that the same cells that arrest in G1 in larva are the one that proliferate in adult? More explanation/data is needed to establish this result.</p></disp-quote><p>The NSCs do not “arrest” in G<sub>1</sub> upon expression of Dap or Rbf280. The transition is delayed rather than blocked, since some are in mitosis (pH3+) and they continue to generate neuronal (ElaV+) progeny (See for example in Figure 5—figure supplement 1l).</p><p>Adult NSCs are identified by expression of Dpn, as well as by GFP under the control of the NSC-specific Worniu-GAL4. The same GAL4-driver is used for overexpression or knockdown during development and is expressed in more than 90% of the NSCs in the VNC. Because there are no Dpn-positive cells in the adult brain that are GFP-negative (data not shown), it seems unlikely that the few NSCs which did not express to the UAS-transgene are the ones that continue to proliferate in the adult.</p><p>The title and the wording of the last Results paragraph have been changed to avoid confusion, and we explain better how adult NSCs are identified.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…] The one key standing question that the authors have not addressed is whether or not the reported Glycolysis-to-OxPhos transition takes place. The finding that OxPhos is needed throughout NSC development casts serious doubts on the physiological need for such a switch to mostly respiratory metabolism. Moreover, the proposed switch rests on slim evidence, i.e. a 1.2 fold increase in OCR (and that is comparing entire brains, not NSCs).</p></disp-quote><p>We agree with the reviewer that the existence of such a switch seems less likely in view of our results. We comment on this in the Discussion, and explain an alternative, and in our view more plausible, interpretation of the data: OxPhos-dependent proliferation is required for temporal patterning and differentiation at the G<sub>1</sub>/S transition of the cell cycle; this enables NSCs to undergo normal aging and respond to the developmental cues that instruct termination of proliferation.</p><disp-quote content-type="editor-comment"><p>Other points:</p><p>&quot;We assessed whether OxPhos inhibition promotes the differentiation and early depletion of the Imp-positive stem cells. This would result in Imp-negative tumour cells with limited self-renewal capacity (Genovese et al., 2018)&quot;. I do not grasp the rationale behind this experiment.</p></disp-quote><p>Growth of pros mutant tumours is known to be sustained by a small proportion of highly proliferative stem cells expressing Imp (Genovese et al., 2018; Narbonne-Reveau et al., 2016). These Imp-positive cells self-renew, but also generate more differentiated tumour-cells that limit tumour growth. Because OxPhos dysfunction reduces tumour growth (Figure 1A-J), we wanted to exclude the possibility that this was a result of increased differentiation towards Imp-negative cells with limited self-renewal capacity. This is now explained in the Results section.</p><disp-quote content-type="editor-comment"><p>The article &quot;in vivo genetic dissection of tumour growth and the Warburg effect&quot; (Wang et al., 2016) should be cited and discussed. It makes a strong claim on the relevance of the Warburg effect in a different type of tumour in flies.</p></disp-quote><p>The article is now presented in the Introduction.</p><disp-quote content-type="editor-comment"><p>Figure 1H, At first, I could not appreciate the blue rim on the aPKC-CAAX cell cartoon (it looked all green to me). Using better contrasted colours might help.</p></disp-quote><p>The colour in the figure has been changed.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>This manuscript examines the requirement for OXPHOS during development of Drosophila neuronal stem cells. Using an RNAi-based approach, the authors demonstrate that disruption of either complex I or complex V slows both normal brain growth and tumor growth. Moreover, this growth phenotype stems from a decreased cell proliferation and defects in temporal patterning.</p><p>Overall, I like the experimental foundation of this paper and I think it will ultimately be quite interesting. While there are experimental shortcomings (see below), the major issue is in regard to the Introduction and Discussion, which fail to place the reader in an appropriate mindset, and as a result, fail to highlight interesting findings. Specifically, the Introduction and Discussion are underdeveloped and devoted a significant number of sentences to providing an overly simplistic discussion of aerobic glycolysis. The text in these sections leads the reader to believe that the paper is devoted to aerobic glycolysis, as evident the final sentence which states that the goal of the study is to examine the role of the Warburg effect in NSCs. Similarly, the first paragraph concludes with a sentence about aerobic glycolysis. But nowhere in the manuscript do the authors examine the role of aerobic glycolysis within NSCs. There are no assays dedicated to studying glycolytic metabolism nor do they disrupt glycolysis in these cells. In fact, they never even measure lactate production – the hallmark byproduct of aerobic glycolysis. I'm not sure why the paper is setup in this manner, other than the possibility that the authors are really annoyed with the inappropriate manner by which other labs sometimes use the term &quot;aerobic glycolysis.&quot;</p><p>This unwarranted focus on aerobic glycolysis produces a manuscript that lacks direction. All experiments are devoted to studying OXPHOS, yet the reader is focused on glycolysis. I recommend that the authors entirely rewrite the Introduction and Discussion with a focus on the importance of OXPHOS in both cancer and normal developmental growth. OXPHOS is clearly essential in both cancer and developmental growth. In fact, the most recent in vivo 13C-glucose labeling experiments in human patients suggest that most tumors are highly dependent on OXPHOS. Here the authors describe a new system for studying the link between OXPHOS and cell proliferation! Describe why these findings regarding OxPhos are important and forget about aerobic glycolysis – unless the authors really want to devote a significant amount to experimental effort (far beyond the scope of a simple revision) to prove their hypothesis that aerobic glycolysis (as defined by elevated glucose consumption and oxygen-independent lactate production) is not important in this context.</p></disp-quote><p>We have refocused the manuscript on the importance of OxPhos in proliferating NSCs.</p><p>- The Introduction explains the importance of OxPhos in proliferating cells.</p><p>- The Discussion has been expanded considerably. We provide more explanation of the discrepancies with Homem et al. We discuss how our findings may impact on the current understanding of NSC diversity and normal temporal patterning of NSCs. We also present our findings in the context of research from the Banerjee lab (Mandal et al., 2010, 2005; Owusu-Ansah et al., 2008).</p><p>- We have now performed knockdown of glycolysis enzymes in NSCs and in tumour cells and included these data in Figure 1, Figure 1—figure supplement 1, 2 and Figure 2—figure supplement 1. This shows that NSC-specific knockdown of PFK, aldolase and PGK does not affect brain size, but knockdown of PyK results in smaller brains. We also tested aldolase knockdown in Pros tumours and found that, in contrast to normal NSCs, their growth is significantly decreased.</p><disp-quote content-type="editor-comment"><p>As a second offshoot of my concern regarding the text, the results herein are clearly related to the studies by Homem et al., 2014, and Mandal et al., 2005, yet, little effort is made to discuss the results in the context of these earlier studies. I don't think that this previous work detracts from the novelty of the study and the lack of discussion is annoying.</p></disp-quote><p>- Mandal et al. and Homem et al. are better explained in the Introduction, and we mention both papers as a motivation to conduct our experiments.</p><p>- We highlight the differences with Homem et al. and discuss in more detail an alternative interpretation of their data based on our findings.</p><p>- Additional experiments (cf below), based on the work from Mandal et al., have now been included in the Results section (Figure 4—figure supplement 2) and are interpreted in the context of (Mandal et al., 2010, 2005; Owusu-Ansah et al., 2008).</p><disp-quote content-type="editor-comment"><p>My other major concern is that the results are descriptive and lack some rather basic metabolic characterizations. Specifically, there is no metabolic characterization of the cells expressing the complex I and complex V RNAi constructs. Since the manuscript argues that these RNAi treatments are disrupting the cell cycle as the result of defects in OXPHOS, the resulting metabolic defects should be characterized. At a minimum, the authors should examine mitochondrial morphology and ATP levels. All of these parameters can be measured using previously published reagents.</p></disp-quote><p>The complex I RNAi line has been used extensively and validated in several previous publications (e.g. Garcia et al., 2017; Hermle et al., 2017; Owusu-Ansah et al., 2013; Pletcher et al., 2019), which we now cite in the Results section.</p><p>To further validate the effect of knockdown of complex I (NDUFS1) and complex V (ATPsynα) on mitochondrial metabolism, we performed the following experiments (Figure 1—figure supplement 2):</p><p>- We assessed mitochondrial morphology using STED super-resolution microscopy (conventional confocal microscopy did not resolve individual mitochondria in an intact brain). Both complex I and complex V knockdown showed increased fragmentation of mitochondria in NSCs (Figure 1—figure supplement 2D-F).</p><p>- We measured ATP concentration in vivo using a previously validated ATP sensor (Tsuyama et al., 2013). Baseline ATP levels were not affected, but after complex V knockdown, NSCs showed a stronger drop in ATP levels upon acute pharmacological inhibition of glycolysis (Figure 1—figure supplement 2G-I), suggesting that this knockdown affects mitochondrial metabolism and results in rewiring cellular metabolism to rely more on glycolysis.</p><disp-quote content-type="editor-comment"><p>Finally, the Results section would be enhanced with a few simple experiments that would make sense in light of previous CoVa (tenured) studies (Mandal et al., 2005), which demonstrate that disruption of Complex IV results in a G<sub>1</sub>/S arrest that is dependent on AMPK and p53. The authors briefly elude to these similarities, but fail to address the model. A few simple genetic experiments, such as determining if RNAi-depletion of AMPK suppresses the OXPHOS-induced defects, would significantly enhance the impact of the study.</p></disp-quote><p>In view of the reviewers’ comments, we assessed both retrograde signalling pathways that were shown to cause G<sub>1</sub>/S arrest by (Mandal et al., 2010, 2005; Owusu-Ansah et al., 2008). Our preliminary data suggest that decreasing ROS does not rescue the proliferation or temporal patterning defects of complex I or V inhibition (data not shown). We also knocked down Ampk and p53 by RNAi, and these did not rescue the effect of OxPhos knockdown (complex I RNAi) either (data not shown).</p><p>We next generated Ampk mutant clones through mitotic recombination, in a background where all NSCs continue to express the complex I or complex V RNAi. This again did not rescue proliferation or temporal patterning, and in fact enhanced rather than suppressed the phenotype. We included these experiments in the Results section (Figure 4—figure supplement 2) and interpret them in the context of (Mandal et al., 2010, 2005; Owusu-Ansah et al., 2008).</p><disp-quote content-type="editor-comment"><p>Reviewer #4:</p><p>[…] I am asking the authors to address the points below:</p><p>While the data showing that KD of OxPhos affects different aspects of NSCs are strong, the argument that OxPhos is affected is only genetic. Given the strength of the authors' claim and the fact that changing the mRNA levels of metabolic enzymes often results in compensatory or unforeseen effects, the authors should validate that their manipulations affect OxPhos using different assays. This would make the manuscript much stronger, as there would be direct, rather than genetic (inferential), data about OxPhos.</p></disp-quote><p>The complex I RNAi line has been used extensively and validated in several previous publications (e.g. Garcia et al., 2017; Hermle et al., 2017; Owusu-Ansah et al., 2013; Pletcher et al., 2019), which we now cite in the Results section.</p><p>To further validate the effect of knockdown of complex I (NDUFS1) and complex V (ATPsynα) on mitochondrial metabolism, we performed the following experiments (Figure 1—figure supplement 2):</p><p>- We assessed mitochondrial morphology using STED super-resolution microscopy (conventional confocal microscopy did not resolve individual mitochondria in an intact brain). Both complex I and complex V knockdown showed increased fragmentation of mitochondria in NSCs (Figure 1—figure supplement 2D-F).</p><p>- We measured ATP concentration in vivo using a previously validated ATP sensor (Tsuyama et al., 2013). Baseline ATP levels were not affected, but after complex V knockdown, NSCs showed a stronger drop in ATP levels upon acute pharmacological inhibition of glycolysis (Figure 1—figure supplement 2G-I), suggesting that this knockdown affects mitochondrial metabolism and results in rewiring cellular metabolism to rely more on glycolysis.</p><disp-quote content-type="editor-comment"><p>OxPhos is dispensable for neuronal function, but required in glia (Volkenhoff, 2015). Since NSC can give rise to glial precursors, and glia in turn can support NSCs proliferation and differentiation, is it possible that the phenotypes observed are due to an absence or change in glia?</p></disp-quote><p>All literature so far, in mammals and <italic>Drosophila</italic> (recently reviewed in Magistretti and Alleman, 2018), including the paper mentioned (Volkenhoff et al., 2015), suggest that glial metabolism is mainly glycolytic, to support the function of neurons through secretion of lactate and alanine.</p><p>Based on the reviewer’s suggestion, we knocked down the same complex I and complex V subunits in glia using Repo-Gal4. Glial knockdown resulted in a decreased mitotic index of NSCs (<xref ref-type="fig" rid="respfig2">Author response image 2D</xref>). However this did not affect temporal patterning, as assessed by the number of Imp-positive NSCs at the end of neurogenesis (<xref ref-type="fig" rid="respfig2">Author response image 2E</xref>).</p><p>In addition, we temporally restricted complex I knockdown, and expressed the RNAi from L1 onwards. At this stage, all cortex glia have already been generated and thus are not affected by the expression of RNAi in NSCs. This also prevented termination of proliferation as shown in <xref ref-type="fig" rid="respfig3">Author response image 3</xref> and indicates that the phenotype is not due to an effect on glia.</p><fig id="respfig2"><label>Author response image 2.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-resp-fig2-v2.tif"/></fig><fig id="respfig3"><label>Author response image 3.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-47887-resp-fig3-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>Given that the brain controls growth of the organism, could changes in brain size, especially when the manipulations result in a smaller brain, be because the larvae are smaller? A way to compare brain size to body length or to another independent metric would be beneficial.</p></disp-quote><p>L3 larvae were always collected at wandering stage in order to synchronize developmental timing. In addition, we quantified larval length at the stage of dissection, and pupal length as a measure for final developmental size. The results are included in Figure 2—figure supplement 2 and did not reveal significant differences between the experimental conditions.</p><disp-quote content-type="editor-comment"><p>The authors use the word &quot;cause&quot; in the Results and Discussion section; however, their experiments show that OxPhos is necessary for proliferation, not that it is sufficient, thus there is no direct evidence that it &quot;causes or drives&quot; temporal patterning, proliferation, and differentiation.</p></disp-quote><p>The title, Abstract and Discussion have been changed to reflect that OxPhos is necessary rather than sufficient for the phenotype. The new title is: “Neural stem cell temporal patterning and brain tumour growth rely on oxidative phosphorylation”</p><disp-quote content-type="editor-comment"><p>There is no GAL4 control in the figures.</p></disp-quote><p>As a control, we crossed the same GAL4-line to an RNAi against mCherry. This controls for the presence of GAL4, the RNAi and the genetic background.</p><disp-quote content-type="editor-comment"><p>There is no validation of the efficacy of the RNAi transgenes by qPCR.</p></disp-quote><p>- The complex I RNAi line has been extensively used and validated in several previous publications (e.g. Garcia et al., 2017; Hermle et al., 2017; Owusu-Ansah et al., 2013; Pletcher et al., 2019), which we now mention in the Results section.</p><p>- We now validated the complex V RNAi line (against Blw) by staining for the Blw protein (ATPsynα), which showed a clear downregulation (Figure 1—figure supplement 2A-C).</p><p>- We also performed a more functional validation of the RNAi-lines as explained above.</p></body></sub-article></article>